PHYTOCANNABINOIDS (2010-2014)

PHYTOCANNABINOIDS & RELATED COMPOUNDS 2010–2014


*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000–2009 List
~Articles/Studies in 2015-2019 List
>Information in Another Section


PHYTOCANNABINOIDS News Articles 2010-2019

AMYRINS~ (Triterpenes that Inhibit the Breakdown of 2-AG. See also TRITERPENES)
ANTHOCYANINS/ANTHOCYADINS (Plant Pigments, Moderately Activate CB1 and CB2 Receptors)
BETA-CARYOPHYLLENE/(E)-BCP + (CB2 Agonist, See also TRANS-CARYOPHYLLENE)
BLACK PEPPER (Contains BETA-CARYOPHYLLENE and Other Terpenes)
CANNABINOIDS and FUNGI (See also ANTI-FUNGAL PROPERTIES)
CANNABINOIDS from CYANOBACTERIA
CANNABINOIDS from TRANSGENIC (GMO) ORGANISMS
CANNABINOIDS IN OTHER PLANTS (See also MAGNOLOL, CHOCOLATE, ECHINACEA, TEA)
CANNABISIN (Compound Found in the Seed Hulls of Cannabis)
CANNADOR (Cannabis Extract in Pill Form)
CANNFLAVIN-A/CANNFLAVIN-B+ (Non-Cannabinoid Compounds Found in Cannabis Sprouts. See also FLAVONOIDS)
CARYOPHYLLENE OXIDE (Activates CB2 Receptors)
CBC/CANNABICHROMENE+ (Phytocannabinoid, Unknown Receptor)
CBD/CANNABIDIOL/GWP-42003*+ (Agonist of the 5-HT1A Receptor, TRPV-2, GPR18 and 1A GPR119; Antagonist of CB1 and CB2, GPR–55 and GPR-18, Inverse Agonist to GPR-3, GPR-6 and GPR-12. Helps Prevent Breakdown of Anandamide)
CBDA/CANNABIDIOLIC ACID+ (Precursor to Cannabidiol)
CBDV/CANNABIDIVARIN/GWP42006 (CB1 Neutral Antagonist [No High])
CBG/CANNABIGEROL+ (CB2 Agonist, Inhibits the Reuptake of Endocannabinoids)
CBGA/CANNABIGEROLIC ACID (Precursor of Cannabigerol)
CBN/CANNABINOL (CB2 Agonist, Weak CB1 Agonist)
C28H34N2O6 (Secondary Metabolite of THC)
CHOCOLATE*+ (Contains a Tiny Amount of Anandamide and Compounds that Block its Breakdown)
CURCUMIN (CB1 Antagonist in Turmeric)
ECHINACEA (Contains CB1 and CB2 Agonists and Inverse Agonists. Prevents Breakdown of Anandamide)
ENTOURAGE EFFECT–PHYTOCANNABINOIDS
EPIDIOLEX~
FLAVONOIDS
GUINEENSINE (Natural Inhibitor of Endocanabinoid Uptake, Causes Endocannabinoid Levels to Rise)

GW-42004 (See CBD/CANNABIDIOL/GWP-42003)
GWP-42006 (See THCV/TETRAHYDROCANNABIVARIN)
HONKIOL (From Magnolia Trees, CB1 Agonist, CB2 Antagonist, See Also 4’-O-METHYLHONOKIOL, MAGNOLOL)
IDRASIL~ (Natural, Phytocannabinoid Pill, Available Only in California)
MAGNOLOL (From Magnolia Trees, CB2 Agonist and GPR-55 Antagonist)
MELILOTUS SUAVEOLENS LEDAB/SWEET MELIOT (May Increase the Number of CB2 Receptors)
NAMISOL (THC Tablet)
NELUMBO NUCIFERA/SACRED LOTUS (Contains a CB2 Antagonist)
NUTMEG/MACE (Prevents Breakdown of Anandamide and 2-AG, Prolonging Their Effects)

4’-O-METHYLHONOKIOL (From Magnolia Trees, CB2 Agonist, Increases 2-AG Levels. See Also MAGNOLOL, HONKIOL)
OLIVE OIL (May Cause a Temporary Upregulation of CB1 Tumor Suppressor Gene)
PHENOLS

PHYTOCANNABINOIDS/PLANT EXTRACTS+
RHODODENDRON
SAFFRON (CB1/CB2 Antagonist)

SATIVEX/NABIXIMOLS/ALMIRALL (THC/CBD Cannabis Extract Oral Spray, Legal in UK, but not USA [50/50 THC/CBD Strain + High Proof Alcohol + Mint Extract + Tiny Spray Bottle = DIY Version!])
TAMOXIFEN (Anti-Cancer Drug from Yew Trees, Activates CB1 and CB2 Receptors) 

TEA (Camellia sinensis L) (Weakly Activates CB1 and CB2 Receptors)
TERPENOIDS/TERPENES+ (Help Cannabinoids Work Better, See Also BETA-CARYOPHYLLENE/(E)-BCP)
THC/TETRAHYDROCANNABINOL+ (CB1, CB2 and GPR-18 Agonist. See also Synthetic THC’s, Marinol, Syndros and Nabilone)
THC ACID/THCA (Non-Psychoactive Precursor of THC)
TETRAHYDROCANNABIORCOL (Activates the TRPA1 Channel)
THCV/TETRAHYDROCANNABIVARIN/GWP-42004+ (CB1 and CB2 Antagonist)
THCVA/TETRAHYDROCANNABIVARIC ACID
TETRAHYDROHONOKIOL
TRANS-CARYOPHYLLENE (CB2 Agonist)
TRITERPENES (See also AMYRINS)

top


AMYRINS
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice. (abst – 2011) https://www.sciencedirect.com/science/article/pii/S0304395911002661
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting CB receptors. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525863/
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full-2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera: Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids (full-2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system. (full – 2013) https://www.academia.edu/14299648/Preventive_and_therapeutic_oral_administration_of_the_pentacyclic_triterpene_%CE%B1_%CE%B2-amyrin_ameliorates_dextran_sulfate_sodium-induced_colitis_in_mice_The_relevance_of_cannabinoid_system
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice. (full – 2014) https://www.jstage.jst.go.jp/article/bpb/37/7/37_b14-00113/_html


ANTHOCYANINS/ANTHOCYADINS
Stable Binding of Alternative Protein-enriched Food Matrices with Concentrated Cranberry Bioflavonoids for Functional Food Applications (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769697/
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874


BETA-CARYOPHYLLENE/(E)-BCP
Phytocannabinoids beyond the Cannabis plant – do they exist? (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Screening for Antiviral Activities of Isolated Compounds from Essential Oils (full-2011) http://www.hindawi.com/journals/ecam/2011/253643/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
Local Peripheral Effects of β-Caryophyllene through CB2 Receptors in Neuropathic Pain in Mice. (full – 2012) http://file.scirp.org/Html/23613.html
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS SATIVA L. (link to PDF– 2011) https://www.researchgate.net/publication/235348187_Variations_in_Terpene_Profiles_of_Different_Strains_of_Cannabis_sativa_L
Cannabis Strains: Do Cannabis Strains Differ? (article – 2012) http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points (chart-2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
top

Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23138934
β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility (full–2013) https://www.academia.edu/24338214/%CE%B2-Caryophyllene_causes_regression_of_endometrial_implants_in_a_rat_model_of_endometriosis_without_affecting_fertility
Towards a better Cannabis drug. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
The endocannabinoid system, cannabinoids, and pain. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury. (full – 2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System (full–2014) https://www.academia.edu/
18184089/Functionalization_of_%CE%B2- Caryophyllene_Generates_Novel_Polypharmacology_in_the_Endocannabinoid_System The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (link to PDF–2014) https://www.researchgate.net/publication/258427503_The_cannabinoid_CB2_receptor-selective_phytocannabinoid_beta-caryophyllene_exerts_analgesic_effects_in_mouse_models_of_inflammatory_and_neuropathic_pain
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (link to download – 2014) https://www.academia.edu/26110122/%CE%B2-Caryophyllene_a_CB2_receptor_agonist_produces_multiple_behavioral_changes_relevant_to_anxiety_and_depression_in_mice
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (click “academia” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+cannabinoid+receptor+2+agonist%2C+%CE%B2-caryophyllene%2C+reduced+voluntary+alcohol+intake+and+attenuated+ethanol- induced+place+preference+and+sensitivity+in+mice&btnG=
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway. (click “themodernfarm” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%CE%B2-Caryophyllene+ameliorates+the+Alzheimer-
like+phenotype+in+APP%2FPS1+Mice+through+CB2+receptor+activation+and+the+PPAR%CE%B3+pathway.&btnG=
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491


BLACK PEPPER 
Screening of selected Asian spices for anti obesity-related bioactivities (abst–2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870


CANNABINOIDS and FUNGI
Indoloditerpenes from a Marine-Derived Fungal Strain of Dichotomomyces cejpii with Antagonistic Activity at GPR18 and Cannabinoid Receptors. (abst – 2014) http://pubs.acs.org/doi/abs/10.1021/np400850g
top


CANNABINOIDS IN OTHER PLANTS
Phytocannabinoids beyond the Cannabis plant – do they exist? (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Analgesic effect of Corydalis yanhusuo in a rat model of trigeminal neuropathic pain (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20855279
Screening of selected Asian spices for anti obesity-related bioactivities (abst–2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
Cannabinoid-like anti-inflammatory compounds from flax fiber (link to PDF–2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
The CB(1) Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin (abst–2012) http://link.springer.com/article/10.1007%2Fs11064-012-0716-2
https://www.semanticscholar.org/paper/The-CB1-Receptor-Mediated-Endocannabinoid-Signaling-Hassanzadeh-Hassanzadeh/2afed97bf91c448cb932adc33aa12d75a301104f
Effect of Nelumbo nucifera Petal Extracts on Lipase, Adipogenesis, Adipolysis, and Central Receptors of Obesity (full–2013) http://www.hindawi.com/journals/ecam/2013/145925/
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OH- Tamoxifen (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/
Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors. (click title for download–2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Secondary+Metabolites+from+Eupenicillium+parvum+and+Their+in+Vitro+…&btnG=
Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum (click “researchgate” for download–2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Identification+of+CB1%2FCB2+Ligands+from+Zanthoxylum+bungeanum&btnG
Anti-hepatitis B virus lignans from the root of Streblus asper. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0960894X13000796
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2. (full – 2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210048/
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression. (full – 2014) https://kundoc.com/pdf-effects-of-chaiyuwendan-decoction-on-endocannabinoids-levels-in-adipose-tissue-o.html
Truffles contain endocannabinoid metabolic enzymes and anandamide (link to PDF–2014) https://www.researchgate.net/publication/269035055_Truffles_contain_endocannabinoid_metabolic_enzymes_and_anandamide
Biocontrol potential of endophytes harbored in Radula marginata (liverwort) from the New Zealand ecosystem (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25100187
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745


CANNABINOIDS from CYANOBACTERIA
Cannabinomimetic lipid from a marine cyanobacterium. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325759/
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748600/
Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium Moorea bouillonii. (abst – 2014) https://www.semanticscholar.org/paper/Mooreamide-A%3A-A-Cannabinomimetic-Lipid-from-the-Mevers-
Matainaho/b0eada068d0f4e9dc24fa3860a09033732069c90


CANNABINOIDS from TRANSGENIC (GMO) ORGANISMS
Investigations into the Hypothesis of Transgenic Cannabis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211569


CANNABISIN 
Concise synthesis of Cannabisin G. (abst – 2010) http://www.sciencedirect.com/science/article/pii/S0960894X10009844?via%3Dihub
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L.). (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0308814612004426
Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cells. (abst – 2013) https://www.sciencedirect.com/science/article/pii/S0308814612018468?via%3Dihub
https://www.semanticscholar.org/paper/Cannabisin-B-induces-autophagic-cell-death-by-the-S-Chen-Hao/984f070b9f6d97fc595c8453c553f8c2c7e19b34
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Characterization of Byproducts Originating from Hemp Oil Processing. (abst – 2014) http://pubs.acs.org/doi/abs/10.1021/jf5044426


CANNADOR
Role of Cannabinoids in Multiple Sclerosis. (link to PDF – 2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. (full – 2012) http://jnnp.bmj.com/content/83/11/1125.long


CANNFLAVIN-A/ CANNFLAVIN-B+
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885748/
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells . (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
top


CARYOPHYLLENE OXIDE 
Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosome cruzi (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671683/


CBC/CANNABICHROMENE
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High- Performance Liquid Chromatography-Tandem Mass Spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967639/
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROM. (full – 2011) http://www.faqs.org/patents/app/20110098348
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14. (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
The intersection between cannabis and cancer in the United States (link to download–2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22The+intersection+between+cannabis+and+cancer+in+the+United+States%22&btnG=
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease (click “academia” for download–2011) https://scholar.google.com/scholar?q=Neuroprotective+effects+of+phytocannabinoid-
based+medicines+in+experimental+models+of+Huntington%27s+disease.&hl=en&as_sdt=0&as_vis=1&oi=scholart
The endocannabinoid system and cancer: therapeutic implication. (click “wiley” for download – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+endocannabinoid+system+and+cancer%3A+therapeutic+implication.++++++++++&btnG
Cannabinoids in children. (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Cannabis—A Valuable Drug That Deserves Better Treatment. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498425/
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
The effect cannabichromene on adult neural stem/progenitor cells (link to download–2013) https://theroc.us/…/The%20effect%20of%20cannabichromene%20on%20adult%20ne…
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases. (full – 2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub


CBD/CANNABIDIOL/GWP-42003*+
The use of Cannabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://www.cannabisclinicians.org/view/case-reports-directory/?gv_search=The+use+of+Cannnabidiol+%28CBD%29+and+Meditation+to+reduce+Binge+Drinking%2C++++&filter_31= &mode=any
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://www.cannabisclinicians.org/view/case-reports-directory/?gv_search=Cluster+A+%26+B+Personality+Disorders+&filter_31=&mode=any
Anxiety Associated with Dying. (case report – undated) http://www.cannabisclinicians.org/view/case-reports-directory/?gv_search=Anxiety+Associated+with+Dying.+++++&filter_31=&mode=any International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2. (full – 2010) http://pharmrev.aspetjournals.org/content/62/4/588.full
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823358/
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Therapeutical use of the cannabinoids in psychiatry. (full – 2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/?tool=pmcentrez
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5- HT1A receptor activation. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. (full – 2010) http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival. (full – 2010) http://mct.aacrjournals.org/content/9/1/180.full
top
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis. (full – 2010) http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High- Performance Liquid Chromatography-Tandem Mass Spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity. (full – 2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. (full – 2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. (full – 2010) http://www.jpsmjournal.com/article/S0885-3924(09)00787-8/fulltext
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. (full – 2010) http://www.mdpi.com/1424-8247/3/8/2647/htm
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke. (full – 2010) http://www.mdpi.com/1424-8247/3/7/2197/htm
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835116/
Simultaneous quantification of cannabinoids and metabolites in oral fluid by two- dimensional gas chromatography mass spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849720/
Standardized Cannabis in Multiple Sclerosis: A Case Report. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Synergistic neuroprotective therapies with hypothermia. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed
Pharmacological characterization of GPR55, a putative cannabinoid receptor. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874616/
US Patent Application 20100204312 – METHODS AND COMPOSITIONS FOR TREATING CANCER. (full – 2010) https://www.google.com/patents/US20100204312
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A) ― 2010-01-16. (full – 2010) https://patents.google.com/patent/TW201002315A/en?oq=Patent++TW201002315++(A)+%E2%80%95+2010-01-16
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218 (full – 2010) http://www.faqs.org/patents/app/20100016218
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. (link to full – 2010) http://bjp.rcpsych.org/content/197/4/285.long
Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors. (link to PDF – 2010) https://www.academia.edu/5174486/Cannabidiol_injected_into_the_bed_nucleus_of_the_stria_terminalis_modulates_baroreflex_activity_through_5HT_1A_receptors Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. (link to PDF – 2010) https://www.researchgate.net/publication/44686140_Treatment_with_cannabidiol_reverses_oxidative_stress_parameters_cognitive_impairment_and_mortality_in_rats_submitted_to_sepsis_by_cecal_ligation_and_puncture
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (download-2010) https://journals.sagepub.com/doi/pdf/10.1177/0269881110379283
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (link to download-2010) https://www.researchgate.net/publication/44683223_Meta-analysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010. (link to download – 2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy. (link to download – 2010) http://www.natap.org/2010/newsUpdates/marijuana.pdf
Antitumorigenic Effects of Cannabinoids beyond Apoptosis. (click “aspetjournals” for download – 2010) http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. (click “archives-ouvertes” for download – 2010) https://scholar.google.com/scholar?q=Cannabidiol+inhibits+cancer+cell+invasion+via+upregulation+of+tissue+inhibitor+of+matrix+metalloproteinases-1&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. (click “psuedu” for download – 2010) https://scholar.google.com/scholar?q=Cannabidiol+bioavailability+after+nasal+and+transdermal+application:+effect+of+permeation+enhancers.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Endocannabinoids and psychiatric disorders: the road ahead. (article – 2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500003&lng=en&nrm=iso&tlng=en
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes. (research summary – 2010) https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/gwmd1092-gw42003gw42004-
together-plus-alone-in-type-ii-diabetes/
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. (abst – 2010) https://www.semanticscholar.org/paper/Intra-dorsal-periaqueductal-gray-administration-of-Soares-Campos/5a40914e011bf7b0c6d77a06b6d4f91de5869632
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20668920
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform- selective and potent inhibitors of human CYP1 enzymes. (abst – 2010) http://www.sciencedirect.com/science/article/pii/S0006295210000663
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20695034
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic- ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer. (abst – 2010) http://www.goldjournal.net/article/S0090-4295(10)00366-3/fulltext
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410650/
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement . (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full – 2011) http://mct.aacrjournals.org/content/10/1/90.full
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096803/
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy. (full – 2011) http://mct.aacrjournals.org/content/10/7/1161.long
Heterogeneity in the composition of marijuana seized in California. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118261/
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC304
1249/ Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. (full – 2011) http://www.clinchem.org/content/57/1/66.long
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. (full – 2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences. (full – 2011) https://www.sciencedirect.com/science/article/pii/S0920996411002246?via%3Dihub
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia- ischemia in newborn pigs. (link to download – 2011) http://www.nature.com/pr/journal/v70/n3/pdf/pr2011171a.pdf
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent. (full – 2011) http://www.medicinalgenomics.com/wp-content/uploads/2013/01/Bergamaschi_2011.pdf
Regulation of nausea and vomiting by cannabinoids. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. (full – 2011) https://journals.sagepub.com/doi/full/10.1177/0269881110389095
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (full–2011) https://www.academia.edu/28110501/Therapeutic_potential_of_cannabidiol_against_ischemia_reperfusion_liver_injury_in_rats
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS. (full – 2011) http://www.faqs.org/patents/app/20110082195
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&l
ocale=en_EP US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism- Related Genes in Microglial Cells (full–2011) https://www.academia.edu/14037654/The_Non-Psychoactive_Plant_Cannabinoid_Cannabidiol_Affects_Cholesterol_Metabolism-
Related_Genes_in_Microglial_Cells
top
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety. (link to PDF – 2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Cannabinoids in oral fluid following passive exposure to marijuana smoke (link to PDF–2011) https://www.researchgate.net/publication/51496380_Cannabinoids_in_oral_fluid_following_passive_exposure_to_marijuana_smoke
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimers’ disease. (link to PDF – 2011) http://molpharm.aspetjournals.org/content/early/2011/02/24/mol.111.071290.long
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress. (link to PDF – 2011) https://www.researchgate.net/publication/51504511_Effects_of_intracisternal_administration_of_cannabidiol_on_the_cardiovascular_and_behavioral_responses_to_acute_restraint_stress
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. (link to PDF – 2011) https://www.researchgate.net/publication/51529545_Sub-chronic_impact_of_cannabinoids_in_street_cannabis_on_cognition_psychotic-like_symptoms_and_psychological_well-being
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. (link to PDF – 2011) https://www.researchgate.net/publication/47729076_The_interplay_of_cannabinoid_and_NMDA_glutamate_receptor_systems_in_hu
mans_Preliminary_evidence_of_interactive_effects_of_cannabidiol_and_ketamine_in_healthy_human_subjects A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. (link to PDF – 2011) https://www.researchgate.net/publication/50249108_A_randomized_double-blind_placebo-controlled_parallel-group_enriched-design_study_of_nabiximols_Sativex_R_as_add-on_therapy_in_subjects_with_refractory_spasticity_caused_by_multiple_sclerosis Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats. (link to PDF – 2011) https://www.researchgate.net/publication/49781028_Effects_on_sleep_and_dopamine_levels_of_microdialysis_perfusion_of_cannabidiol_into_the_lateral_hypothalamus_of_rats
Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6 (link to PDF–2011) https://www.researchgate.net/publication/51552208_Cannabidiol_a_Major_Phytocannabinoid_As_a_Potent_Atypical_Inhibitor_for_CYP2D6
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA. (link to download in English, link to French-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Cannabidiol, a Major Phytocannabinoid, as a Potent Atypical Inhibitor for Cytochrome P450 2D6. (link to download–2011) http://dmd.aspetjournals.org/content/early/2011/08/05/dmd.111.041384.long
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells (link to download–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids. (link to download – 2011) http://www.dovepress.com/articles.php?article_id=7675
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L.). (link to download – 2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. (link to download – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility. (link to download – 2011) https://www.academia.edu/14021759/Inhibitory_Effect_of_Standardized_Cannabis_sativa_Extract_and_Its_Ingredient_Cannabidiol_on_Rat_and_Human_Bladder_Contractility
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. (link to download – 2011) http://www.nature.com/cddis/journal/v2/n6/pdf/cddis201152a.pdf
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa. (link to download – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
The potential for clinical use of cannabinoids in treatment of cardiovascular diseases. (link to download – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2010.00233.x/pdf
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors. (click “researchgate” for download – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+potentiates+%CE%949-tetrahydrocannabinol+%28THC%29+behavioural+effects+and+alters+THC+pharmacokinetics+during+acute+and+chronic+treatment +in+adolescent+rats&btnG= Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. (click “rocmexico” for download – 2011) https://scholar.google.com/scholar?q=Cannabidiol+inhibits+lung+cancer+cell+invasion+and+metastasis+via+intercellular+adhesion+molecule-1.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. (click “researchgate” for download – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+potentiates+%CE%94%E2%81%B9-tetrahydrocannabinol+%28THC%29+behavioural+effects+and+alters+THC+pharmacokinetics+during+acute+and+chronic+treatment +in+adolescent+rats.&btnG= Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. (click “medicinal genomics” for download–2011) https://scholar.google.com/scholar?q=Identification+of+cytochrome+P450+enzymes+responsible+for+metabolism+of+cannabidiol+by+human+liver+microsomes.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Migraines, Marijuana, and Chocolate. (article – 2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
top
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents. (abst – 2011) https://www.ncbi.nlm.nih.gov/pubmed/21726355
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors. (abst – 2011) http://heart.bmj.com/content/97/24/e8.9.abstract
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-010-2157-4 https://www.semanticscholar.org/paper/Interaction-between-non-psychotropic-cannabinoids-Rock-Goodwin/af477df7b3ede4912f70c78c98660e25fc8cdc69
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0028390811003467
https://www.semanticscholar.org/paper/Effect-of-cannabidiol-on-sleep-disruption-induced-Hsiao-Yi/41c135101f114558ee8e3d7ef7a54cc16b1c2203
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation. (abst – 2011) http://www.abstractsonline.com/plan/ViewAbstract.aspx?sKey=94b35de1-74b2-4d46-b062-7c104b5df681&cKey=eca34a2d-da44-4938-b0fa-3a6e652a1756
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive- compulsive behaviour. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-011-2415-0
https://www.semanticscholar.org/paper/Plasma-and-brain-pharmacokinetic-profile-of-(CBD)%2C-Deiana-Watanabe/dfc11f2878a906a6a68316691d9182d02111851a
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0166432811002567
https://www.semanticscholar.org/paper/Effect-of-cannabidiol-in-a-MK-801-rodent-model-of-Gururajan-Taylor/6e3a7fe1698c2426ac0e1f36e84568fc8b5fbe9a
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol(abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
A preliminary investigation on the distribution of cannabinoids in man. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21570784/abstract/A_preliminary_investigation_on_the_distribution_of_cannabinoids_in_man_
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury. (abst – 2011) https://www.semanticscholar.org/paper/Cannabidiol-treated-Rats-Exhibited-Higher-Motor-Kwiatkoski-Guimar%C3%A3es/2709387cc1e16182d293a9f86abaa555b6708f41 THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (abst – 2011) https://www.semanticscholar.org/paper/THC-and-CBD-oromucosal-spray-(Sativex%C2%AE)-in-the-of-Sastre-Garriga-
Vila/4aff95e12c30cb7420e8705c55e59f965b6ae29d
top
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells. (abst – 2011) http://eprints.hud.ac.uk/16197/
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21870037
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20471992/abstract/Cannabidiol_induced_a_contrasting_pro_apoptotic_effect_between_freshly_isolated_and_precultured_human_monocytes_
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21492165/abstract/A_synthetic_cannabinoid_CP55940_inhibits_lipopolysaccharide_induced_cytokine_mRNA_expression_in_a_cannabinoid_receptor_independent_mechanism_in_rat_cerebellar_granule_cells_
Effect of cannabidiol treatment in alimentary induced fatty liver. (abst – 2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-010-2157-4 https://www.semanticscholar.org/paper/Interaction-between-non-psychotropic-cannabinoids-Rock-Goodwin/af477df7b3ede4912f70c78c98660e25fc8cdc69
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21693551
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726418
Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21636228
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21381415/abstract/%5BSimultaneous_determination_of_delta_9_tetrahydrocannabinol_cannabidiol_and_cannabinol_in_edible_oil_using_ultra_performance_liquid_chromatography_tandem_mass_spectrometry %5D_
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://www.sciencedirect.com/science/article/pii/S030439401100437X?via%3Dihub
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0378874110008202
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
top
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug. (full – 2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388241/
Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma- associated herpesvirus-infected endothelium. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984/
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor. (full – 2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
The Therapeutic Potential of Cannabis and Cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature. (full – 2012) http://www.harmreductionjournal.com/content/9/1/7
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. (full – 2012) http://www.seizure-journal.com/article/S1059
-1311%2812%2900057-X/fulltext Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
top
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells. (full – 2012) http://www.spandidos-publications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?text=fulltext
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398715/
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. (full – 2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
Cannabidiol inhibits angiogenesis by multiple mechanisms. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Cannabidiol in humans-the quest for therapeutic targets. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test. (full – 2012) http://www.sciencedirect.com/science/article/pii/S0278584612002801
Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol. (full – 2012) http://file.scirp.org/Html/17302.html
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats. (full – 2012) http://journals.sagepub.com/doi/full/10.1177/0269881112441865
Cannabinoids: A new hope for breast cancer therapy? (full – 2012) http://www.academia.edu/23263803/Cannabinoids_A_new_hope_for_breast_cancer_therapy
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319321/
Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717347/
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (full – 2012) https://www.cambridge.org/core/journals/primary-health-care-research-and-development/article/questionnaire-survey-of-patients-and-
carers-of-patients-prescribed-sativex-as-an-unlicensed-medicine/BEE125598FE8E6E92EC01F33DC5F149D/core-reader
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. (full – 2012) https://www.academia.edu/15170913/Cannabidiol_injected_into_the_bed_nucleus_of_the_stria_terminalis_reduces_the_expression_of_contextual_fear_conditioning_via_5-HT1A_receptors
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. (link to PDF– 2012) https://www.researchgate.net/publication/232066502_Cannabidiol_inhibits_THC-elicited_paranoid_symptoms_and_hippocampal-dependent_memory_impairment
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice. (link to PDF – 2012) http://www.karger.com/Article/FullText/336871
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9- Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia. (link to PDF – 2012) http://www.eurekaselect.com/102848/article
Cannabinoid-like anti-inflammatory compounds from flax fiber. (link to PDF – 2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats (link to PDF–2012) https://www.researchgate.net/publication/237044761_Involvement_of_serotonin-
mediated_neurotransmission_in_the_dorsal_periaqueductal_gray_matter_on_cannabidiol_chronic_effects_in_panic- like_responses_in_rats
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns (link to PDF–2012) https://www.researchgate.net/publication/224867439_Cannabinol_and_cannabidiol_exert_opposing_effects_on_rat_feeding_patterns
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (link to PDF – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Heat+Exposure+of+Cannabis+sativa+Extracts+Affects+the+Pharmacokinetic+and+Metabolic+Profile+in+Healthy+Male+Subjects.++++++++++++&btnG=
Phytocannabinoids as novel therapeutic agents in CNS disorders. (link to PDF – 2012) https://www.researchgate.net/publication/51648721_Phytocannabinoids_as_novel_therapeutic_agents_in_CNS_disorders
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. (link to PDF – 2012) https://www.researchgate.net/publication/227707560_Acute_Effects_of_a_Single_Oral_dose_of_d9-tetrahydrocannabinol_THC_and_Cannabidiol_CBD_Administration_in_Healthy_Volunteers
Towards the use of non-psychoactive cannabinoids for prostate cancer (link to download–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. (link to download – 2012) https://www.theroc.us/researchlibrary/Cannabidiol%20affects%20the%20expression%20of%20genes%20involved%20in%20zinc%20homeostasis%20in%20BV-2%20microglial%20cells.pdf
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors. (link to download – 2012) https://www.academia.edu/21961147/Cannabidiol_blocks_long-lasting_behavioral_consequences_of_predator_threat_stress_Possible_involvement_of_5HT1A_receptors
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation. (link to download– 2012) http://www.eurekaselect.com/102849/article
top
Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. (click “unito” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Simultaneous+analysis+of+several+synthetic+cannabinoids%2C+THC%2C+CBD+and+CBN%2C+in+hair+by+ultra-high+performance+liquid+chromatography+tandem+mass+spectrometry.+Method+validation+and+application+to+real+samples.+++ +++++++&btnG
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG= The therapeutic potential of the endocannabinoid system for Alzheimer’s disease. (click “alchimiaweb” for download – 2012) https://scholar.google.com/scholar?q=The+therapeutic+potential+of+the+endocannabinoid+system+for+Alzheimer%27s+disease&hl=en&as_sdt=0&as_vis=1&oi=scholart
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. (click “academia” for download – 2012) https://scholar.google.com/scholar?q=Chemopreventive+effect+of+the+non-
psychotropic+phytocannabinoid+cannabidiol+on+experimental+colon+cancer.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview. (click “rocmexico” for download – 2012) https://scholar.google.com/scholar?q=Cannabidiol+in+Inflammatory+Bowel+Diseases:+A+Brief+Overview.&hl=en&as_sdt=0&as_vis=1&oi=scholart
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (click “researchgate” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+double-blind%2C+randomized%2C+placebo-controlled%2C+parallel-group+study+of+THC%2FCBD+oromucosal+spray+in+combination+with+the+existing+treatment+regimen%2C+in+the+relief+of+central+neuropathic+pain+in+patients+with+multiple+sclerosis.&btnG
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. (click “theroc” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+administration+after+hypoxia%E2%80%93ischemia+to+newborn+rats+reduces+long-term+brain+injury+and+restores+neurobehavioral+function&btnG
Cannabis Strains: Do Cannabis Strains Differ? (article – 2012) http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
The potential use of cannabidiol in the therapy of metabolic syndrome. (abst in English – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005 (link to full in Hungarian – 2012) https://akademiai.com/doi/abs/10.1556/OH.2012.29308
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. (abst in English – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861 (abst in Spanish – 2012) https://www.neurologia.com/articulo/2012362
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23109356
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabis-derivatives-therapy-for-a-seronegative-a-Vicente-Valor-Garcia-Llopis/08926d1160224a16a1b8ae6cdcc4810ebe467b0b
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0168365912003318
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) https://www.sciencedirect.com/science/article/pii/S0944711312001249?via%3Dihub
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
Cannabidiol-induced apoptosis in murine microglial cells through lipid raft. (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22345/abstract
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabidiol-for-the-treatment-of-cannabis-syndrome%3A-Crippa-Hallak/b932e4334e490493ed91b84b187b8ebe906c6e4f
MicroRNAs and their role in the generation of myeloid derived suppressor cells (MDSC) by cannabidiol in vivo. (abst – 2012) http://www.jimmunol.org/content/188/1_Supplement/48.16
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. (abst – 2012) https://www.semanticscholar.org/paper/Endothelium-dependent-mechanisms-of-the-effect-of-Baranowska-Kuczko-Maclean/6a1726529a5444318b14fa889546050a8f529a0c
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures. (abst – 2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabis-derivatives-therapy-for-a-seronegative-a-Vicente-Valor-Garcia-Llopis/08926d1160224a16a1b8ae6cdcc4810ebe467b0b
Distribution of free and conjugated cannabinoids in human bile samples. (abst – 2012) https://www.semanticscholar.org/paper/Distribution-of-free-and-conjugated-cannabinoids-in-Fabritius-Staub/607db7f1f6ce6873db87ca3ba75b5b71fa0d56c7 Id-1 gene and protein as novel therapeutic targets for metastatic cancer. (abst – 2012) http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
top
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. (abst – 2012) https://www.semanticscholar.org/paper/First-systematic-evaluation-of-the-potency-of-grown-Bruci-Papoutsis/3d18eacca6c5e342ef26ad73fd7fea27aa137fa7
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment- resistant epilepsy. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594064/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120. (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476243/
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
Modulating the endocannabinoid system in human health and disease: successes and failures. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684164/
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. (full – 2013) http://www.springerplus.com/content/2/1/236
Is the cardiovascular system a therapeutic target for cannabidiol? (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full – 2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain. (full – 2013) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000400380&lng=en&nrm=iso&tlng=en
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells. (full – 2013) http://mct.aacrjournals.org/content/12/1/69.long
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. (full – 2013) https://www.sciencedirect.com/science/article/pii/S2173580814000674
The endocannabinoid system, cannabinoids, and pain. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703206/
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full – 2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/full
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838683/
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules. (full – 2013) http://ar.iiarjournals.org/content/33/10/4373.long
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid- Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634783/
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants. (full – 2013) http://www.mdpi.com/1420-3049/18/10/12663/htm
Cannabis, a complex plant: different compounds and different effects on individuals. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758774/
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9- Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102264/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control). (full – 2013) http://www.freepatentsonline.com/y2013/0245110.html
Transdermal delivery of cannabidiol Patent 8435556. (full – 2013) https://www.google.com/patents/US8435556
Why should Cannabis be Considered Doping in Sports? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
US Patent 8106244 B2 Process for production of delta-9-tetrahydrocannabinol. (full – 2012) http://www.google.com/patents/US8106244
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience. (full – 2013) https://docksci.com/effects-of-intra-infralimbic-prefrontal-cortex-injections-of-cannabidiol-in-the-_5a62c735d64ab2c4e6b72006.html
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076918
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice. (full – 2013) https://www.academia.edu/26662974/The_role_of_potassium_BK_channels_in_anticonvulsant_effect_of_cannabidiol_in_pentylenetetrazole_and_maximal_electroshock_models_of_seizure_in_mice Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. (full – 2013) https://www.academia.edu/23260168/Effects_of_cannabidiol_on_the_function_of_%CE%B17-nicotinic_acetylcholine_receptors
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior. (full – 2013) https://www.academia.edu/23675947/Cannabidiol_reverses_the_mCPP-induced_increase_in_marble-burying_behavior
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060314
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. (link to PDF – 2013) https://www.researchgate.net/publication/235366318_Effects_of_acute_systemic_administration_of_cannabidiol_on_sleep- wake_cycle_in_rats
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (link to PDF – 2013) https://www.researchgate.net/publication/235905283_Natural_Cannabinoids_Improve_Dopamine_Neurotransmission_and_Tau_and_
Amyloid_Pathology_in_a_Mouse_Model_of_Tauopathy
Industrial hemp decreases intestinal motility stronger than indian hemp in mice. (link to PDF – 2013) http://www.europeanreview.org/article/3266
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement. (link to PDF – 2013) https://www.researchgate.net/publication/259003402_Cannabidiol_Promotes_Amyloid_Precursor_Protein_Ubiquitination_and_Reduction_of_Beta_Amyloid_Expression_in_SHSY5Y_APP_Cells_Through_PPARg_Involvement Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. (link to PDF – 2013) https://www.researchgate.net/publication/253334787_Cannabinoids_Decrease_the_Th17_Inflammatory_Autoimmune_Phenotype
Development and validation of an LC-MS/MS method for quantification of Δ9- tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair (link to PDF–2013) https://www.researchgate.net/publication/235398312_Development_and_validation_of_an_LC-MSMS_method_for_quantification_of_Delta_9-tetrahydrocannabinolic_acid_A_THCA-A_THC_CBN_and_CBD_in_hair A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray. (link to PDF – 2013) https://www.researchgate.net/publication/264266057_A_Multiple-Dose_Randomized_Double-Blind_Placebo-Controlled_Parallel-Group_QTQTc_Study_to_Evaluate_the_Electrophysiologic_Effects_of_THCCBD_Spray
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. (download – 2013) https://www.sciencedirect.com/science/article/pii/S1043466613007345
Cannabidiol as potential anticancer drug. (link to download – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04298.x/pdf
Whole Cannabis Extracts of High Concentration Cannabidiol May Calm Seizures in Highly Refractory Pediatric Epilepsies. (link to download – 2013) http://hope4childrenwithepilepsy.com/wp-content/uploads/2013/11/Dr.-Gedde-Abstract.pdf
Role of endogenous cannabinoid system in the gut. (link to download – 2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency. (link to download – 2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. (link to download – 2013) https://scholar.google.com/scholar?q=Cannabinoid-+and+lysophosphatidylinositol-
sensitive+receptor+GPR55+boosts+neurotransmitter+release+at+central+synapses&hl=en&as_sdt=0&as_vis=1&oi=scholart
Protective effect of cannabidiol against cadmium hepatotoxicity in rats. (link to download – 2013) Protective effect of cannabidiol against cadmium hepatotoxicity in rats Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19. (link to download – 2013) https://www.jstage.jst.go.jp/article/dmpk/28/4/28_DMPK-12-RG-129/_pdf
The effect cannabichromene on adult neural stem/progenitor cells. (link to download-2013) https://theroc.us/…/The%20effect%20of%20cannabichromene%20on%20adult%20ne…
top
Endocannabinoid system and mood disorders: Priming a target for new therapies. (click “academia” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Endocannabinoid+system+and+mood+disorders%3A+Priming+a+target+for+new+therapies&btnG=
Therapeutic potential of cannabinoid medicines. (click “psu” for download – 2013) https://scholar.google.com/scholar?q=%22+Therapeutic+potential+of+cannabinoid+medicines%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack- like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae). (click “sagepub” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+role+of+5-HT1A+receptors+in+the+anti-aversive+effects+of+cannabidiol+on+panic+attack- like+behaviors+evoked+in+the+presence+of+the+wild+snake+Epicrates+cenchria+crassus+%28Reptilia%2C+Boidae%29&btnG=
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT₁A receptor. (click “academia” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+administration+into+the+bed+nucleus+of+the+stria+terminalis+alters+cardiovascular+responses+induced+by+acute+restraint+stress+through+5-HT%E2%82%81A+receptor.&btnG
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. (click “uni-meunchen” for download – 2013) https://scholar.google.com/scholar?q=Anti-inflammatory+role+of+cannabidiol+and+O-1602+in+cerulein-induced+acute+pancreatitis+in+mice.&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings. (click “alchimiaweb” for download – 2013) https://scholar.google.com/scholar?q=Cannabidiol+reduces+cigarette+consumption+in+tobacco+smokers:+Preliminary+findings.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors. (click “researchgate” for download – 2013) https://scholar.google.com/scholar?q=Mechanisms+of+cannabidiol+neuroprotection+in+hypoxic%E2%80%93ischemic+newborn+pigs:+Role+of+5HT1A+and+CB2+receptors&hl=en&as_sdt=0&as_vis=1&oi=scholart
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. (click “medicinalgenomics” for download – 2013) https://scholar.google.com/scholar?q=Neuroprotection+and+reduction+of+glial+reaction+by+cannabidiol+treatment+after+sciatic+nerve+transection+in+neonatal+rats.&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabidiol as a potential treatment for psychosis. (click “academia” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+as+a+potential+treatment+for+psychosis&btnG
Do cannabinoids exhibit a tyramine-like effect? (click “unibonn” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Do+cannabinoids+exhibit+a+tyramine-like+effect%3F&btnG
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors. (letter – 2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900115-2/fulltext
INTERVIEW : Martin Lee of Project CBD (interview – 2013) http://www.ladybud.com/2013/11/12/interview-martin-lee-of-project-cbd/
top
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L. (abst – 2013) https://link.springer.com/article/10.1007/BF00276675?no-access=true
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) https://www.semanticscholar.org/paper/Cannabidiol-enhances-consolidation-of-explicit-fear-Das-Kamboj/47536f6343c7526e3f50517dc0b4504b12bf23f6
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. (abst – 2013) https://www.semanticscholar.org/paper/Cannabidiol-inhibits-the-reward-facilitating-effect-Katsidoni-Anagnostou/945696289e053540e65e17f313da96c8cf5498f7
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. (abst – 2013) http://www.tandfonline.com/doi/full/10.3109/03602532.2013.849268
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24088353
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5- HT1A receptors activation in mice. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0166432813002532
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria. (abst – 2013) https://www.fasebj.org/doi/10.1096/fasebj.27.1_supplement.1097.9
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon. (abst – 2013) http://www.fasebj.org/content/26/1_Supplement/1123.1
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23721741
top
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro. (abst – 2013) https://www.semanticscholar.org/paper/Cannabinoid-Effects-on-%CE%B2-Amyloid-Fibril-and-and-In-Janefjord-
Maag/641ebdd551d8ae69283c3ace38d72755e8d957eb Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24120371
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis. (abst – 2013) http://www.jni-journal.com/article/S0165
-5728(13)00051-9/fulltext Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0091305712002985
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0006295213007478
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Cannabinoids Control Breast Cancer Progression Through Id-1. (abst – 2013) http://grantome.com/grant/NIH/R01-CA135281-01A2
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. (full – 2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies. (full – 2014) http://www.karger.com/Article/FullText/357742
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. (full – 2014) http://www.jci.org/articles/view/64628
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC39
15876/ Cyclosporine and Herbal Supplement Interactions. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913293/
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954478/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium. (full – 2014) http://ajpgi.physiology.org/content/307/2/G140
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration. (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy . (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
The case for medical marijuana in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabinoids for epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009270.pub3/full
The case for assessing cannabidiol in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12635/full
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997281/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9- tetrahydrocannabinol (THC) by vaporization . (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Potential effects of cannabidiol as a wake-promoting agent. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023456/
Endocannabinoid signalling and the deteriorating brain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209152/
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. (full – 2014) http://mct.aacrjournals.org/content/13/12/2955.long
Cannabidiol improves vasorelaxation in Zucker Diabetic fatty rats through cyclooxygenase activation. (full – 2014) http://jpet.aspetjournals.org/content/351/2/457.long
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons. (full – 2014) http://www.jbc.org/content/289/36/24845.long
Cannabinoids in experimental stroke: a systematic review and meta-analysis (full2014) http://jcb.sagepub.com/content/35/3/348.long
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362971/
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9- tetrahydrocannabinol in Sprague-Dawley rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376456/
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines. (full – 2014) http://file.scirp.org/Html/5-2500510_47691.htm
Cannabidiol: Promise and Pitfalls. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189631/
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Cannabinoids as therapeutic agents in cancer: current status and future implications (full-2014) http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233&path%5B%5D=3664
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells. (full – 2014) https://academic.oup.com/intimm/article-lookup/doi/10.1093/intimm/dxu097
Physicians, Medical Marijuana, and the Law. (full – 2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis. (full – 2014) http://www.neurology.org/content/82/12/1083.full
top
Anti-tumoural effects of cannabinoid combinations – US 8632825 B2. (full – 2014) https://www.google.com/patents/US8632825?dq=patent+cannabinoid&hl=en&sa=X&ei=M1DyU6KwDYHcOuy6gLgF&ved=0CDM
Q6AEwAw
Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets . (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106080/
Cannabis in the Management and Treatment of Seizures and Epilepsy: A Scientific Review. (full – 2014) https://herbal-ahp.org/scientific-review-cannabis-epilepsy-and-seizures/
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience. (full – 2014) http://www.karger.com/Article/FullText/357743
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial. (full – 2014) https://www.academia.edu/13394739/Effects_of_cannabidiol_in_the_treatment_of_patients_with_Parkinsons_disease_an_exploratory
_double-blind_trial Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis. (link to PDF – 2014) https://www.researchgate.net/publication/267272822_Evaluation_of_the_tolerability_and_efficacy_of_Sativex_in_multiple_sclerosis
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice. (link to PDF – 2014) https://www.researchgate.net/publication/263934508_Long-
Term_Cannabidiol_Treatment_Prevents_the_Development_of_Social_Recognition_Memory_Deficits_in_Alzheimer’s_Disease_Trans genic_Mice Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice. (link to PDF – 2014) https://www.researchgate.net/publication/264833175_Cannabis-
Based_Medicine_Reduces_Multiple_Pathological_Processes_in_AbPPPS1_Mice Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury. (link to PDF – 2014) https://www.researchgate.net/publication/267735571_Cannabidiol_improves_lung_function_and_inflammation_in_mice_submitted_to_LPS-induced_acute_lung_injury
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. (link to PDF – 2014) https://www.researchgate.net/publication/262109303_Intrahypothalamic_injection_of_cannabidiol_increases_the_extracellular_levels_of_adenosine_in_nucleus_accumbens_in_rats
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. (link to PDF – 2014) https://www.researchgate.net/publication/260915159_Voltage-gated_sodium_NaV_channel_blockade_by_plant_cannabinoids_does_not_confer_anticonvulsant_effects_per_se
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability. (link to PDF – 2014) https://www.researchgate.net/publication/263971332_Nonpsychotropic_Plant_Cannabinoids_Cannabidivarin_CBDV_and_Cannabidiol_CBD_Activate_and_Desensitize_Transient_Receptor_Potential_Vanilloid_1_TRPV1_Channels_in_Vitro_Potential_for_the_Treat ment_of_Neur
Early phytocannabinoid chemistry to endocannabinoids and beyond (link to PDF–2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. (download – 2014) https://cbd-b.be/wp-content/uploads/2018/09/2014-Antidepressant-Like-and-Anxiolytic-Like-Effects-of-Cannabidiol.pdf
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (download – 2014) https://www.semanticscholar.org/paper/Delta-9-Tetrahydrocannabinol%2FCannabidiol-A-Review-Syed-McKeage/e2dadf2f60dcfbfd189b9b908673c2179af16de5
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (link to download – 2014) http://www.karger.com/Article/Pdf/367615
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice. (link to download – 2014) https://www.researchgate.net/publication/260430828_Chronic_cannabidiol_treatment_improves_social_and_object_recognition_in_double_transgenic_APPswePS1DE9_mice
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical- Grade Cannabis. (link to download – 2014) https://bedrocan.com/wp-content/uploads/2014-therapeutic-satisfaction-and-subjective-effects-of-different-strains-of-pharmaceutical-grade-cannabis_-brunt.pdf
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet. (link to download – 2014) http://www.jpp.krakow.pl/journal/archive/08_14/pdf/487_08_14_article.pdf
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (click “academia” for download – 2014) https://scholar.google.com/scholar?q=Inhibition+of+colon+carcinogenesis+by+a+standardized+Cannabis+sativa+extract+with+high+content+of+cannabidiol&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection . (click “medicinal genonomics” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+normalizes+caspase+3%2C+synaptophysin%2C+and+mitochondrial+fission+protein+DNM1L+expression+levels+in+rats+with+brain+iron+overload%3A+implications+for+neuroprotection. &btnG=
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. (click “academia” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Protective+Effects+of+Cannabidiol+Against+Hippocampal+Cell+Death+and+Cognitive+Impairment+Induced+by+Bilateral+Common+Carotid+Artery+Occlusion+in+Mice&btnG
Cannabinoid-induced changes in respiration of brain mitochondria. (click “cuni” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoid-induced+changes+in+respiration+of+brain+mitochondria&btnG
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (click “theroc” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+can+improve+complex+sleep-related+behaviours+associated+with+rapid+eye+movement+sleep+behaviour+disorder+in+Parkinson%27s+disease+patients%3A+a+ case+series.&btnG
Report on Medical Cannabis Research History- What the Science Says. (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis- related spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24464350
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814000978?via%3Dihub
https://www.semanticscholar.org/paper/The-detection-of-THC%2C-CBD-and-CBN-in-the-oral-fluid-Molnar-Fu/d49d12e576d1bc3ce430746bc011e9c3d12ba4ab
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM. (abst – 2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS. PROGRAM. (abst – 2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006295214003608
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington’s disease may depend on their functional selectivity. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.846.6
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.1048.19
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE- ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006295214004201
https://www.semanticscholar.org/paper/Cannabinoids-increase-lung-cancer-cell-lysis-by-via-Haustein-Ramer/ae2a0a45c3a3e896a9986642c922fe6713526d08
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response. (abst – 2014) https://www.epilepsybehavior.com/article/S1525-5050(14)00413-2/fulltext
top
Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate antinociception induced by transcutaneous electrostimulation of the peripheral nervous system. (abst – 2014) https://europepmc.org/abstract/med/25282545
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S1355030614001075?via%3Dihub
Potential applications of marijuana and cannabinoids in medicine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25485642
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS. (abst – 2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S1388198114002674
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME. (abst – 2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868186#sthash.4suBa1in.dpuf
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548


CBDA/CANNABIDIOLIC ACID
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218. (full – 2010) http://www.faqs.org/patents/app/20100016218
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
The draft genome and transcriptome of Cannabis sativa. (link to download – 2011) http://genomebiology.com/content/pdf/gb-2011-12-10-r102.pdf
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14. (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&l
ocale=en_EP
Cannabis as a Unique functional food. (link to download – 2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_acid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA- MB-231 breast cancer cell migration. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009504/
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (link to PDF – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Heat+Exposure+of+Cannabis+sativa+Extracts+Affects+the+Pharmacokinetic+and+Metabolic+Profile+in+Healthy+Male+Subjects.++++++++++++&btnG=
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0161813X11002245
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24088353
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0091305713002098
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. (link to PDF–2014) https://www.jstage.jst.go.jp/article/jts/39/5/39_711/_article
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS. (abst – 2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
top


CBDV/CANNABIDIVARIN/GWP42006+
Anticonvulsant effects of GWP42006 in vitro and in vivo in rat. (abst – 2010) http://www.physoc.org/proceedings/abstract/Proc%20Physiol%20Soc%2019C117
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive- compulsive behaviour. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-011-2415-0
https://www.semanticscholar.org/paper/Plasma-and-brain-pharmacokinetic-profile-of-(CBD)%2C-Deiana-Watanabe/dfc11f2878a906a6a68316691d9182d02111851a
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726418
Cannabidivarin is anticonvulsant in mouse and rat. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525866/
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249141/
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy. (full – 2012) https://patents.google.com/patent/US20120004251A1/en
The effect of GWP42006, a cannabinoid extract on MCF-7 human breast carcinoma cells. (link to PDF – 2012) https://www.researchgate.net/publication/280040300_%27The_effect_of_GWP42006_a_cannabinoid_extract_on_MCF-7_human_breast_carcinoma_cells
Phytocannabinoids as novel therapeutic agents in CNS disorders. (link to PDF – 2012) https://www.researchgate.net/publication/51648721_Phytocannabinoids_as_novel_therapeutic_agents_in_CNS_disorders
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840466/
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 – tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792004/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Cannabis in the Management and Treatment of Seizures and Epilepsy: A Scientific Review. (full – 2014) https://herbal-ahp.org/scientific-review-cannabis-epilepsy-and-seizures/
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability (link to PDF–2014) https://www.researchgate.net/publication/263971332_Nonpsychotropic_Plant_Cannabinoids_Cannabidivarin_CBDV_and_Cannabidiol_CBD_Activate_and_Desensitize_Transient_Receptor_Potential_Vanilloid_1_TRPV1_Channels_in_Vitro_Potential_for_the_Treat ment_of_Neur
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
top


CBG/CANNABIGEROL*+
Patent application title: THERAPEUTIC USES OF CANNABIGEROL. (full – 2010) http://www.faqs.org/patents/app/20100292345
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/?tool=pubmed
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218. (full – 2010) http://www.faqs.org/patents/app/20100016218
Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption. (link to PDF- 2010) https://www.researchgate.net/publication/45112236_Detection_of_cannabigerol_and_its_presumptive_metabolite_in_human_urine_after_Cannabis_consumption
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa). (full – 2011) https://www.academia.edu/20285332/Bioactive_Prenylogous_Cannabinoid_from_Fiber_Hemp_Cannabis_sativa_
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14. (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa. (link to download – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Migraines, Marijuana, and Chocolate. (article – 2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-010-2157-4
https://www.semanticscholar.org/paper/Interaction-between-non-psychotropic-cannabinoids-Rock-Goodwin/af477df7b3ede4912f70c78c98660e25fc8cdc69
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-011-2415-0
https://www.semanticscholar.org/paper/Plasma-and-brain-pharmacokinetic-profile-of-(CBD)%2C-Deiana-Watanabe/dfc11f2878a906a6a68316691d9182d02111851a
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Phytocannabinoids as novel therapeutic agents in CNS disorders. (link to PDF – 2012) https://www.researchgate.net/publication/51648721_Phytocannabinoids_as_novel_therapeutic_agents_in_CNS_disorders
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (link to PDF – 2012) https://www.researchgate.net/publication/230841397_A_Cannabigerol_Quinone_Alleviates_Neuroinflammation_in_a_Chronic_Model_of_Multiple_Sclerosis
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
The effect cannabichromene on adult neural stem/progenitor cells (link to download–2013) https://theroc.us/…/The%20effect%20of%20cannabichromene%20on%20adult%20ne…
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. (click “ medicinalgenonomics” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Beneficial+effect+of+the+non-psychotropic+plant+cannabinoid+cannabigerol+on+experimental+inflammatory+bowel+disease&btnG
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells. (abst – 2013) https://www.fasebj.org/doi/10.1096/fasebj.27.1_supplement.1105.21
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0091305712002985
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells (abst–2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis- derived non-psychotropic cannabinoid. (full – 2014) http://carcin.oxfordjournals.org/content/35/12/2787.long
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. (link to PDF – 2014) https://www.researchgate.net/publication/260915159_Voltage-
gated_sodium_NaV_channel_blockade_by_plant_cannabinoids_does_not_confer_anticonvulsant_effects_per_se The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.1048.19
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis- derived non-psychotropic cannabinoid. (full – 2014) http://carcin.oxfordjournals.org/content/35/12/2787.long
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. (link to PDF – 2014) https://www.researchgate.net/publication/260915159_Voltage-gated_sodium_NaV_channel_blockade_by_plant_cannabinoids_does_not_confer_anticonvulsant_effects_per_se
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.1048.19
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
top


CBGA/CANNABIGEROLIC ACID+
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218. (full – 2010) http://www.faqs.org/patents/app/20100016218
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726418
Structure and Function of Δ1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0022283612005220
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916817/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases. (full – 2014) http://www.mdpi.com/1420-3049/19/11/18781/htm


CBN/CANNABINOL
Simultaneous quantification of cannabinoids and metabolites in oral fluid by two- dimensional gas chromatography mass spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849720/
Standardized Cannabis in Multiple Sclerosis: A Case Report. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218. (full – 2010) http://www.faqs.org/patents/app/20100016218
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform- selective and potent inhibitors of human CYP1 enzymes. (abst – 2010) http://www.sciencedirect.com/science/article/pii/S0006295210000663
Cannabinoids in oral fluid following passive exposure to marijuana smoke. (link to PDF – 2011) https://www.researchgate.net/publication/51496380_Cannabinoids_in_oral_fluid_following_passive_exposure_to_marijuana_smoke
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21381415/abstract/%5BSimultaneous_determination_of_delta_9_tetrahydrocannabinol_cannabidiol_and_cannabinol_in_edible_oil_using_ultra_performance_liquid_chromatography_tandem_mass_spectrometry %5D_
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
A preliminary investigation on the distribution of cannabinoids in man. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21570784/abstract/A_preliminary_investigation_on_the_distribution_of_cannabinoids_in_man_
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717347/
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319321/
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. (link to PDF – 2012) https://www.researchgate.net/publication/224867439_Cannabinol_and_cannabidiol_exert_opposing_effects_on_rat_feeding_patterns
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-
microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. (click “unito” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Simultaneous+analysis+of+several+synthetic+cannabinoids%2C+THC%2C+CBD+and+CBN%2C+in+hair+by+ultra-high+performance+liquid+chromatography+tandem+mass+spectrometry.+Method+validation+and+application+to+real+samples.+++ +++++++&btnG
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Distribution of free and conjugated cannabinoids in human bile samples. (abst – 2012) https://www.semanticscholar.org/paper/Distribution-of-free-and-conjugated-cannabinoids-in-Fabritius-Staub/607db7f1f6ce6873db87ca3ba75b5b71fa0d56c7
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. (abst – 2012) https://www.semanticscholar.org/paper/First-systematic-evaluation-of-the-potency-of-grown-Bruci-Papoutsis/3d18eacca6c5e342ef26ad73fd7fea27aa137fa7
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. (abst – 2012) https://www.semanticscholar.org/paper/First-systematic-evaluation-of-the-potency-of-grown-Bruci-Papoutsis/3d18eacca6c5e342ef26ad73fd7fea27aa137fa7
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9- Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102264/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
Transdermal delivery of cannabidiol Patent 8435556. (full – 2013) https://www.google.com/patents/US8435556
Development and validation of an LC-MS/MS method for quantification of Δ9- tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair (link to PDF–2013) https://www.researchgate.net/publication/235398312_Development_and_validation_of_an_LC-MSMS_method_for_quantification_of_Delta_9-tetrahydrocannabinolic_acid_A_THCA-A_THC_CBN_and_CBD_in_hair
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. (abst – 2013) http://www.tandfonline.com/doi/full/10.3109/03602532.2013.849268
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362971/
Cannabinoids as therapeutic agents in cancer: current status and future implications. (full – 2014) http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233&path%5B%5D=3664
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. (link to PDF– 2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCA-
A_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke
Early phytocannabinoid chemistry to endocannabinoids and beyond. (link to PDF– 2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814000978?via%3Dihub
https://www.semanticscholar.org/paper/The-detection-of-THC%2C-CBD-and-CBN-in-the-oral-fluid-Molnar-Fu/d49d12e576d1bc3ce430746bc011e9c3d12ba4ab
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S1355030614001075?via%3Dihub
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Potential applications of marijuana and cannabinoids in medicine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
top


C28H34N2O6
Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer’s disorders using molecular docking and molecular dynamics simulation (full – 2014) http://www.hindawi.com/journals/bri/2014/705451/


CHOCOLATE*+
Migraines, Marijuana, and Chocolate. (article – 2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Sexuality, heart and chocolate. (abst in English – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23547364
(click “unige” for download in French – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Sexuality%2C+heart+and+chocolate%22&btnG


CURCUMIN
Nutritional Interventions for Cancer-induced Cachexia. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106221/
Screening of selected Asian spices for anti obesity-related bioactivities. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870
The role of phytochemicals in the treatment and prevention of dementia. (abst – 2011) http://link.springer.com/article/10.2165%2F11591310-000000000-00000
The CB(1) Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin. (abst – 2012) http://link.springer.com/article/10.1007%2Fs11064-012-0716-2
https://www.semanticscholar.org/paper/The-CB1-Receptor-Mediated-Endocannabinoid-Signaling-Hassanzadeh-
Hassanzadeh/2afed97bf91c448cb932adc33aa12d75a301104f Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0014299913006961
https://www.semanticscholar.org/paper/Curcumin-modulates-cannabinoid-receptors-in-liver-Zhang-
Guo/925df391d0ecd1234be297025cfae09cc5784d6c


ECHINACEA
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors (full–2011) https://www.academia.edu/14975971/Alkamides_and_a_neolignan_from_Echinacea_purpurea_roots_and_the_interaction_of_alkamides_with_G-protein-coupled_cannabinoid_receptors


ENTOURAGE EFFECT–PHYTOCANNABINOIDS
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival. (full – 2010) http://mct.aacrjournals.org/content/9/1/180.full
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Standardized Cannabis in Multiple Sclerosis: A Case Report. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967639/
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats. (link to PDF – 2010) https://www.researchgate.net/publication/42611557_Cannabis_constituents_modulate_9-tetrahydrocannabinol-induced_hyperphagia_in_rats
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice. (link to PDF – 2014) https://www.researchgate.net/publication/264833175_Cannabis-
Based_Medicine_Reduces_Multiple_Pathological_Processes_in_AbPPPS1_Mice EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM. (abst – 2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS. PROGRAM. (abst – 2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
top


FLAVONOIDS
Phytocannabinoids beyond the Cannabis plant – do they exist? (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Stable Binding of Alternative Protein-enriched Food Matrices with Concentrated Cranberry Bioflavonoids for Functional Food Applications. (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769697/
Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa: Link between Genes and Metabolites. (full – 2013) http
://www.mdpi.com/1422-0067/14/7/13626/htm
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage (link to PDF–2013) https://www.researchgate.net/publication/236108070_Ethephon_application_stimulats_cannabinoids_and_plastidic_terpenoids_production_in_Cannabis_sativa_at_flowering_stage
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874


GUINEENSINE
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. (full – 2014) https://www.academia.edu/20107281/Guineensine_is_a_novel_inhibitor_of_endocannabinoid_uptake_showing_cannabimimetic_beha
vioral_effects_in_BALB_c_mice


HONKIOL
Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. (full – 2010) http://carcin.oxfordjournals.org/content/31/11/2004.long
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
top
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase- 1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2- dependent signals. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958642/
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220322/
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123370/
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018490
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. (link to download – 2011) http://www.nature.com/ijos/journal/v3/n1/pdf/ijos20116a.pdf
Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro- inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage. (link to download – 2010) https://www.jstage.jst.go.jp/article/jphs/114/1/114_10070FP/_pdf
Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S1567576911002220
Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22126780
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation. (abst – 2011) https://www.semanticscholar.org/paper/Honokiol-rescues-sepsis-associated-acute-lung-and-Weng-Wu/b2009f2bb4d85222f9893eab329b65d500860d24
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1- dependent pathway and inhibits breast carcinogenesis. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496153/
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis. (full – 2012) https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-017-0829-2
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. (full – 2012) http://mct.aacrjournals.org/content/11/4/963.long
Antimetastatic activity of honokiol in osteosarcoma. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Honokiol attenuates torsion/detorsion-induced testicular injury in rat testis by way of suppressing endoplasmic reticulum stress-related apoptosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22285174
Multiple effects of Honokiol on the life cycle of hepatitis C virus. (abst – 2012) https://www.semanticscholar.org/paper/Multiple-effects-of-Honokiol-on-the-life-cycle-of-C-Lan-
Wang/8793370db913854acfd18dfd314adca9b9790170 Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22258232
Neuro-modulating effects of honokiol: a review. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769637/
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813738/
Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523945/
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1. (full – 2013) http://www.spandidos-publications.com/ijo/43/4/1103?text=fulltext
Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/jor.22577/full
Honokiol as a Radiosensitizing Agent for Colorectal cancers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844429/
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments. (link to download – 2013) http://www.ddtjournal.com/action/downloaddoc.php?docid=687
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition. (full – 2014) http://www.spandidos-publications.com/ijo/44/
1/187;jsessionid=D37A8D6D01845D28427059EB11FE132D?text=fulltext Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244131/
Honokiol inhibits androgen receptor activity in prostate cancer cells. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946953/
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433539/
Honokiol inhibits melanoma stem cells by targeting notch signaling. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776032/
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA- MB231 breast cancer cells. (link to PDF – 2014) https://www.researchgate.net/publication/259628954_Magnolia_dealbata_seeds_extract_exert_cytotoxic_and_chemopreventive_effects_on_MDA-MB231_breast_cancer_cells
Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0927776513008114
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. (abst – 2014) https://www.semanticscholar.org/paper/Potential-use-of-Magnolia-officinalis-bark-in-the-Coppola-Mondola/111ab8266bd84a02bdd2c8c1f89da91deb249f49
Effect of Honokiol on Proliferation and Apoptosis in HL-60 Cells and Its Potential Mechanism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25543478
In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. (abst – 2014) https://www.semanticscholar.org/paper/In-vitro-and-in-vivo-antimicrobial-efficacy-of-of-Kim-Kim/0a95d7c736b34a83b5b71ec7ae1cea5d84f8929d


MAGNOLOL+
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
Magnolol Ameliorates Ligature-Induced Periodontitis in Rats and Osteoclastogenesis: In Vivo and In Vitro Study. (full – 2013) http://www.hindawi.com/journals/ecam/2013/634095/
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice. (full – 2013) https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. (full – 2013) http://www.spandidos-publications.com/ijo/43/2/600
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827615/
Autophagy triggered by magnolol derivative negatively regulates angiogenesis. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920944/
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway. (link to PDF – 2013) https://www.researchgate.net/publication/258066613_Magnolol_induces_apoptosis_in_MCF-
7_human_breast_cancer_cells_through_G2M_phase_arrest_and_caspase-independent_pathway Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells. (link to PDF– 2013) https://www.researchgate.net/publication/255953009_Magnolol_induces_apoptosis_via_caspase-independent_pathways_in_non-small_cell_lung_cancer_cells
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments. (link to download – 2013) http://www.ddtjournal.com/action/downloaddoc.php?docid=687
Resuscitation from experimental traumatic brain injury by magnolol therapy. (click “nctuedu” for download – 2013) https://scholar.google.com/scholar?q=Resuscitation+from+experimental+traumatic+brain+injury+by+magnolol+therapy&hl=en&as_sdt=0&as_vis=1&oi=scholart
Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3- kinase/akt signaling pathways. (abst – 2013) https://www.semanticscholar.org/paper/Magnolol-suppresses-vascular-endothelial-growth-by-Kim-Kim/3fb75b430cdf669a6d567b426e7f6305829629fa
Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice. (abst – 2013) https://link.springer.com/article/10.1007%2Fs10753-012-9507-9
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23972358
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0014482713003157
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells. (abst – 2013) https://link.springer.com/article/10.1007%2Fs10753-013-9631-1
https://www.semanticscholar.org/paper/Magnolol-Inhibits-LPS-Induced-Inflammatory-Response-Luo-Xu/3fc2fce895e091044bb0bdbe10c13effa29047e4
Anti-hepatitis B virus lignans from the root of Streblus asper. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0960894X13000796
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0006295213001135
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans. (full – 2014) https://onlinelibrary.wiley.com/doi/full/10.1111/jam.12737
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells. (full – 2014) https://www.mdpi.com/1420-3049/19/1/1223/htm
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA- MB231 breast cancer cells. (link to PDF – 2014) https://www.researchgate.net/publication/259628954_Magnolia_dealbata_seeds_extract_exert_cytotoxic_and_chemopreventive_effects_on_MDA-MB231_breast_cancer_cells
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. (abst – 2014) https://www.semanticscholar.org/paper/Potential-use-of-Magnolia-officinalis-bark-in-the-Coppola-Mondola/111ab8266bd84a02bdd2c8c1f89da91deb249f49
In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. (abst – 2014) https://www.semanticscholar.org/paper/In-vitro-and-in-vivo-antimicrobial-efficacy-of-of-Kim-Kim/0a95d7c736b34a83b5b71ec7ae1cea5d84f8929d
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0041008X14002646
https://www.semanticscholar.org/paper/Magnolol-protects-neurons-against-ischemia-injury-Chen-Kuo/97bec619eaf3d3a2802924f1ec5486cb3442c57d
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24974464
top


MELILOTUS SUAVEOLENS LEDAB/SWEET MELIOT
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/


NAMISOL
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial. (click “runl” for download – 2014) https://scholar.google.com/scholar?q=Safety+and+pharmacokinetics+of+oral+delta-9-
tetrahydrocannabinol+in+healthy+older+subjects:+A+randomized+controlled+trial&hl=en&as_sdt=0&as_vis=1&oi=scholart


NELUMBO NUCIFERA/SACRED LOTUS 
Effect of Nelumbo nucifera Petal Extracts on Lipase, Adipogenesis, Adipolysis, and Central Receptors of Obesity (full–2013) http://www.hindawi.com/journals/ecam/2013/145925/


NUTMEG/MACE
Screening of selected Asian spices for anti obesity-related bioactivities. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870
In search of endocannabinoid degradation enzymes inhibitors in nutmeg. (abst – 2013) http://www.fasebj.org/content/27/1_Supplement/1097.5?utm_source=TrendMD&utm_medium=cpc&utm_campaign=FASEB_J_Tren
dMD_0
top


4’-O-METHYLHONOKIOL
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. (full – 2010) https://kundoc.com/pdf-inhibitory-effect-of-ethanol-extract-of-magnolia-officinalis-and-4-o-methylhonok.html
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity. (abst – 2012) https://www.ncbi.nlm.nih.gov/pubmed/22330831


PHENOLS
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L. (link to PDF – 2012) https://www.researchgate.net/publication/260824507_Effect_of_extraction_conditions_on_total_polyphenol_contents_antioxidant_and_antimicrobial_activities_of_Cannabis_sativa_L
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt. (abst – 2014) https://www.semanticscholar.org/paper/Effective-Phytoextraction-of-Cadmium-(Cd)-with-of-Ahmad-Hadi/b6b3639f18e41b0beb1ef08a853e3f6802b1b0ba
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. (abst – 2014) https://www.semanticscholar.org/paper/Potential-use-of-Magnolia-officinalis-bark-in-the-Coppola-Mondola/111ab8266bd84a02bdd2c8c1f89da91deb249f49
Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S1093326314000035
https://www.semanticscholar.org/paper/Antileishmanial-phytochemical-phenolics%3A-molecular-Ogungbe-Erwin/b8ab7d4ab90e07070b94fbda6514ea03c7504b6b


PHYTOCANNABINOIDS/PLANT EXTRACTS
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931567/?tool=pubmed
Phytocannabinoids beyond the Cannabis plant – do they exist? (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. (full – 2010) http://www.jpsmjournal.com/article/S0885-3924(09)00787-8/fulltext
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835116/
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223. (full – 2010) http://www.faqs.org/patents/app/20100249223
CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS Patent application number: 20100239693. (full – 2010) http://www.faqs.org/patents/app/20100239693
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS. (link to PDF – 2010) https://www.researchgate.net/publication/216536386_Ameliorative_potential_of_cannabis_sativa_extract_on_diabetes_induced_neuropathic_pain_in_rats
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats. (link to PDF – 2010) https://www.researchgate.net/publication/42611557_Cannabis_constituents_modulate_9-tetrahydrocannabinol-induced_hyperphagia_in_rats
A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. (link to PDF – 2010) https://www.researchgate.net/publication/232241501_A_low-D9tetrahydrocannabinol_cannabis_extract_induces_hyperphagia_in_rats
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. (link to PDF – 2010) https://www.researchgate.net/publication/38028401_Non-CB1_Non-
CB2_Receptors_for_Endocannabinoids_Plant_Cannabinoids_and_Synthetic_Cannabimimetics_Focus_on_G-protein- coupled_Receptors_and_Transient_Receptor_Potential_Channels
Antibacterial analysis of crude extracts from the leaves of Tagetes erecta and Cannabis sativa. (link to download – 2010) http://www.ipublishing.co.in/ijesarticles/twelve/articles/voltwo/EIJES3150.pdf
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins. (link to download – 2010) https://www.researchgate.net/publication/44581135_Comparative_topical_anti-
inflammatory_activity_of_cannabinoids_and_cannabivarins
Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. (click “leidenuniv” for download – 2010) https://scholar.google.com/scholar?cluster=480727757513022810&hl=en&as_sdt=0,5&as_vis=1
Variation in Δ9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L. During Different Stages of Growth. (abst – 2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251775
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform- selective and potent inhibitors of human CYP1 enzymes. (abst – 2010) http://www.sciencedirect.com/science/article/pii/S0006295210000663
Gut feelings about the endocannabinoid system. (full – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
top
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
Effect of various concentrations of Crocus sativus and Cannabis sativa extracts on luminescent biosensor Escherichia coli SM10 S1. (full – 2011) http://jjm.ajums.ac.ir/_jjm/documents/Issue%2012,%20S35-41MM.pdf
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14. (full – 2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. (link to PDF – 2011) https://www.researchgate.net/publication/49735602_Cannabis_sativa_and_the_Endogenous_Cannabinoid_System_Therapeutic_Potential_for_Appetite_Regulation Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L.). (link to download – 2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa. (link to download – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease. (click “academia” for download – 2011) https://scholar.google.com/scholar?q=Neuroprotective+effects+of+phytocannabinoid-
based+medicines+in+experimental+models+of+Huntington%27s+disease.&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabinoids: occurrence and medicinal chemistry. (click “researchgate” for download – 2011) https://scholar.google.com/scholar?q=%22Cannabinoids:+occurrence+and+medicinal+chemistry.%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabinoids: potential targets for bladder dysfunction. (click “the-eye” for download – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoids%3A+potential+targets+for+bladder+dysfunction.&btnG
The role of phytochemicals in the treatment and prevention of dementia. (abst – 2011) http://link.springer.com/article/10.2165%2F11591310-000000000-00000
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0378874110008202
top
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS . (abst – 2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS. (abst – 2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=246119
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING. (abst – 2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS. (abst – 2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Isolation and characterization of some phytochemicals from Indian traditional plants. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529893/
The Endocannabinoid System: Cannabinoids in Diabetes and Diabetic Complications. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
The Therapeutic Potential of Cannabis and Cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Cannabinoid-associated cell death mechanisms in tumor models (Review). (full – 2012) http://www.spandidos-publications.com/ijo/41/2/407
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report. (full – 2012) http://file.scirp.org/Html/9-2500130_16958.htm
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. (full – 2012) http://jnnp.bmj.com/content/83/11/1125.long
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476512/
Antimicrobial Activity of Cannabis sativa L. (full – 2012) http://file.scirp.org/Html/10-8801078_18123.htm
Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full–2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
Non-Δ9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (full–2012) https://journals.lww.com/behaviouralpharm/fulltext/2012/02000/Non__9tetrahydrocannabinol_phytocannabinoids.12.aspx?casa_token=CszIAaLHGBQAAAAA:H7LEx_KuBxSoPRkfgDYZdAKv9M_Es_-04ot6wS4glUrqOqM- 8svXDmvuO261ynLK9Aa1R9eCUKQdT88HrZOH9uXr
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L. (link to PDF – 2012) https://www.researchgate.net/publication/260824507_Effect_of_extraction_conditions_on_total_polyphenol_contents_antioxidant_and_antimicrobial_activities_of_Cannabis_sativa_L
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (link to PDF – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Heat+Exposure+of+Cannabis+sativa+Extracts+Affects+the+Pharmacokinetic+and+Metabolic+Profile+in+Healthy+Male+Subjects.++++++++++++&btnG= Phytocannabinoids as novel therapeutic agents in CNS disorders (link to PDF–2012) https://www.researchgate.net/publication/51648721_Phytocannabinoids_as_novel_therapeutic_agents_in_CNS_disorders
Nature Against Depression. (link to PDF – 2012) https://www.researchgate.net/publication/221892079_Nature_Against_Depression
Marijuana: modern medical chimaera. (download – 2012) Marijuana: Modern Medical Chimaera – Semantic Scholar The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis. (click “stcmch” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+biology+that+underpins+the+therapeutic+potential+of+cannabis-based+medicines+for+the+control+of+spasticity+in+multiple+sclerosis&btnG Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model. (abst – 2012) https://www.sciencedirect.com/science/article/pii/S0944711312000402?via%3Dihub
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures. (abst – 2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material. (abst – 2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1307524
NEUROPROTECTIVE EFFECTS OF CANNABIS SATIVA ALCOHOLIC EXTRACT AGAINST SPINAL ALPHA MOTONEURONS DEGENERATION IN MALE TYPE II DIABETIC RATS. (abst – 2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=278407
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis. (abst – 2012) https://www.semanticscholar.org/paper/Cost-Effectiveness-of-Oromucosal-Cannabis-Based-for-Lu-Pearce/7cdfdacafb20ea0ef8c65546ab2d1035fb06ab96
Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332149/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013)
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Cannabis, a complex plant: different compounds and different effects on individuals. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Towards a better Cannabis drug. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study. (full – 2013) http://www.cghjournal.org/article/S1542-3565%2813%2900604-6/fulltext
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules. (full – 2013) http://ar.iiarjournals.org/content/33/10/4373.long
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER. (full – 2013) http://www.google.com/patents/US20130059018
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage. (link to PDF – 2013) https://www.researchgate.net/publication/236108070_Ethephon_application_stimulats_cannabinoids_and_plastidic_terpenoids_produ
ction_in_Cannabis_sativa_at_flowering_stage Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (link to PDF – 2013) https://www.researchgate.net/publication/235905283_Natural_Cannabinoids_Improve_Dopamine_Neurotransmission_and_Tau_and_
Amyloid_Pathology_in_a_Mouse_Model_of_Tauopathy The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms (link to PDF–2013) https://www.researchgate.net/publication/258212395_The_Medicinal_Use_of_Cannabis_and_Cannabinoids-An_International_Cross-Sectional_Survey_on_Administration_Forms
The pharmacologic and clinical effects of medical cannabis. (download – 2013) The Pharmacologic and Clinical Effects of Medical Cannabis Part I of the American Herbal Pharmacopoeia cannabis monograph (Preview) (link to download – 2013) http://american-safe-access.s3.amazonaws.com/documents/AHP_Cannabis_Monograph_Preview.pdf
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract. (link to download – 2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
Whole Cannabis Extracts of High Concentration Cannabidiol May Calm Seizures in Highly Refractory Pediatric Epilepsies. (link to download – 2013) http://hope4childrenwithepilepsy.com/wp-content/uploads/2013/11/Dr.-Gedde-Abstract.pdf
top
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats. (link to download – 2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L. (abst – 2013) https://link.springer.com/article/10.1007/BF00276675?no-access=true
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells. (abst – 2013) https://www.fasebj.org/doi/10.1096/fasebj.27.1_supplement.1105.21
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells . (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
Optimisation and characterisation of marihuana extracts obtained by supercritical fluid extraction and focused ultrasound extraction and retention time locking GC-MS. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23505258
Current and future drugs for treatment of MS-associated bladder dysfunction. (full in English & French – 2014) http://www.sciencedirect.com/science/article/pii/S187706571401728X
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
The case for medical marijuana in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9- tetrahydrocannabinol (THC) by vaporization . (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered- Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study. (full – 2014) https://www.academia.edu/22926463/The_Pharmacokinetics_Efficacy_Safety_and_Ease_of_Use_of_a_Novel_Portable_Metered-Dose_Cannabis_Inhaler_in_Patients_With_Chronic_Neuropathic_Pain_A_Phase_1a_Study
Cannabis in the Management and Treatment of Seizures and Epilepsy: A Scientific Review. (full – 2014) https://herbal-ahp.org/scientific-review-cannabis-epilepsy-and-seizures/
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice. (link to PDF – 2014) https://www.researchgate.net/publication/264833175_Cannabis-
Based_Medicine_Reduces_Multiple_Pathological_Processes_in_AbPPPS1_Mice
Re-branding cannabis: the next generation of chronic pain medicine? (link to PDF – 2014) https://www.researchgate.net/publication/270004454_Re-branding_cannabis_the_next_generation_of_chronic_pain_medicine
Early phytocannabinoid chemistry to endocannabinoids and beyond . (link to PDF– 2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (click “academia” for download – 2014) https://scholar.google.com/scholar?q=Inhibition+of+colon+carcinogenesis+by+a+standardized+Cannabis+sativa+extract+with+high+content+of+cannabidiol&hl=en&as_sdt=0&as_vis=1&oi=scholart
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (click “academia” for download – 2014) https://scholar.google.com/scholar?q=Inhibition+of+colon+carcinogenesis+by+a+standardized+Cannabis+sativa+extract+with+high+content+of+cannabidiol&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabis for inflammatory bowel disease. (abst – 2014) https://www.karger.com/Article/Abstract/358155
(click “stcm” for download of presentation – 2014) https://scholar.google.com/scholar?cluster=16944833097871417927&hl=en&as_sdt=0,5
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
Potential applications of marijuana and cannabinoids in medicine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS. (abst – 2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
top


RHODODENDRON
New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides. (full – 2011) https://www.jstage.jst.go.jp/article/cpb/59/11/59_11_1409/_pdf
Daurichromenic acid-producing oxidocyclase in the young leaves of Rhododendron dauricum. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25918805


SAFFRON 
The role of phytochemicals in the treatment and prevention of dementia (abst–2011) http://link.springer.com/article/10.2165%2F11591310-000000000-00000
top


SATIVEX/NABIXIMOLS/ALMIRALL
Summary of Product Characteristics- Sativex Oralmucosal Spray. (full – 2010) http://www.medicines.org.uk/EMC/medicine/23262/SPC/Sativex+Oromucosal+Spray/
Investigational pharmacology for low back pain. (full – 2010) ` http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004649/?tool=pmcentrez
The endocannabinoid system as a target for the treatment of neurodegenerative disease. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders. (link to download – 2010) http://www.eurekaselect.com/85221/article
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. (link to download – 2010) https://www.researchgate.net/publication/44683223_Meta-analysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. (click “sagepub” for download – 2010) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Randomized+controlled+trial+of+Sativex+to+treat+detrusor+overactivity+in+multiple+sclerosis.&btnG=
Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. (full – 2011) http://www.clinchem.org/content/57/1/66.long
Subjective and physiological effects after controlled Sativex and oral THC administration. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836266/
Role of Cannabinoids in Multiple Sclerosis. (link to PDF – 2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. (link to PDF – 2011) https://www.researchgate.net/publication/50249108_A_randomized_double-blind_placebo-controlled_parallel-group_enriched-design_study_of_nabiximols_Sativex_R_as_add-on_therapy_in_subjects_with_refractory_spasticity_caused_by_multiple_sclerosis Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids. (link to download – 2011) http://www.dovepress.com/articles.php?article_id=7675
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease. (click “academia” for download – 2011) https://scholar.google.com/scholar?q=Neuroprotective+effects+of+phytocannabinoid-
based+medicines+in+experimental+models+of+Huntington%27s+disease.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21542664
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21671456
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (abst – 2011) https://www.semanticscholar.org/paper/THC-and-CBD-oromucosal-spray-(Sativex%C2%AE)-in-the-of-Sastre-Garriga-Vila/4aff95e12c30cb7420e8705c55e59f965b6ae29d
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
The Therapeutic Potential of Cannabis and Cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols). (full – 2012) http://msj.sagepub.com/content/18/2/219.long
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612560/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (full – 2012) https://www.cambridge.org/core/journals/primary-health-care-research-and-development/article/questionnaire-survey-of-patients-and-
carers-of-patients-prescribed-sativex-as-an-unlicensed-medicine/BEE125598FE8E6E92EC01F33DC5F149D/core-reader
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System. (link to PDF – 2012) https://www.researchgate.net/publication/224960858_Potential_Control_of_Multiple_Sclerosis_by_Cannabis_and_the_Endocannabinoid_System
Towards the use of non-psychoactive cannabinoids for prostate cancer. (link to download – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02
121.x/pdf Cannabinoids: Novel Medicines for the Treatment of Huntington’s Disease. (link to download – 2012) http://www.eurekaselect.com/89300/article
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (click “researchgate” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+double-blind%2C+randomized%2C+placebo-
controlled%2C+parallel-group+study+of+THC%2FCBD+oromucosal+spray+in+combination+with+the+existing+treatment+regimen%2C+in+the+relief+of+central+neuropathic+pain+in+patients+with+multiple+sclerosis.&btnG
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. (abst in English – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
(abst in Spanish – 2012) https://www.neurologia.com/articulo/2012362
Neuromodulators for pain management in rheumatoid arthritis. (abst in English, links to abst in Spanish & French – 2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S1526590012000193
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst – 2012) https://www.semanticscholar.org/paper/Evaluation-of-the-safety-and-tolerability-profile-Wade/64518f787b41ec3 11fe2d364e491f82ef206b57d
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis. (abst – 2012) https://www.semanticscholar.org/paper/Cost-Effectiveness-of-Oromucosal-Cannabis-Based-for-Lu-Pearce/7cdfdacafb20ea0ef8c65546ab2d1035fb06ab96
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabis-derivatives-therapy-for-a-seronegative-a-Vicente-Valor-Garcia-Llopis/08926d1160224a16a1b8ae6cdcc4810ebe467b0b
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. (full – 2013) http://www.springerplus.com/content/2/1/236
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
Multiple sclerosis and the blood-central nervous system barrier. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain. (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900238-8/fulltext
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758774/
top
Current knowledge on cannabinoids in oral fluid. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1514/full
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060314
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (link to PDF – 2013) https://www.researchgate.net/publication/235905283_Natural_Cannabinoids_Improve_Dopamine_Neurotransmission_and_Tau_and_Amyloid_Pathology_in_a_Mouse_Model_of_Tauopathy A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group
QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray. (link to PDF – 2013) https://www.researchgate.net/publication/264266057_A_Multiple-Dose_Randomized_Double-Blind_Placebo-Controlled_Parallel-
Group_QTQTc_Study_to_Evaluate_the_Electrophysiologic_Effects_of_THCCBD_Spray The pharmacologic and clinical effects of medical cannabis. (download – 2013) The Pharmacologic and Clinical Effects of Medical Cannabis Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Using cannabinoids in pain and palliative care. (abst – 2013) https://www.magonlinelibrary.com/doi/10.12968/ijpn.2010.16.10.79211
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
Getting high on the endocannabinoid system. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Medical marijuana for cancer. (full – 2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
top
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial. (full – 2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1812720
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary. (full – 2014) http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Endocannabinoid signalling and the deteriorating brain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis. (full – 2014) http://www.neurology.org/content/82/12/1083.full
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience. (full – 2014) http://www.karger.com/Article/FullText/357743
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/cns.12262/full
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis. (link to PDF – 2014) https://www.researchgate.net/publication/267272822_Evaluation_of_the_tolerability_and_efficacy_of_Sativex_in_multiple_sclerosis
Early phytocannabinoid chemistry to endocannabinoids and beyond. (link to PDF– 2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (download – 2014) Delta-9-tetrahydrocannabinol/Cannabidiol for Spasticity in Multiple … Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (link to download – 2014) http://www.karger.com/Article/Pdf/367615
Report on Medical Cannabis Research History- What the Science Says. (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis- related spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
top
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814000978?via%3Dihub
https://www.semanticscholar.org/paper/The-detection-of-THC%2C-CBD-and-CBN-in-the-oral-fluid-Molnar-
Fu/d49d12e576d1bc3ce430746bc011e9c3d12ba4ab Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice. (abst – 2014) https://www.semanticscholar.org/paper/Long-term-effectiveness-and-safety-of-nabiximols-in-Flachenecker-
Henze/037d31eef2e9ea2a482537333a9ecfb79e90e30c Cannabinoid mouth spray brought help to a severely spastic young man. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25158585
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886


TAMOXIFEN 
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OH- Tamoxifen. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/


TEA (Camellia sinensis L)
Tea catechins’ affinity for human cannabinoid receptors. (full – 2010) http://www.thefreelibrary.com/Tea+catechins%27+affinity+for+human+cannabinoid+receptors.-a0221094461
Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953590/
Effects of Hemp (Cannabis sativa L.) Seed Oil Press-Cake and Decaffeinated Green Tea Leaves (Camellia sinensis) on Functional Characteristics of Gluten-Free Crackers. (full – 2014) https://docksci.com/effects-of-hemp-cannabis-sativa-l-seed-oil-press-cake-and-decaffeinated-green-te_5b00ee94d64ab2fe13bcb8de.html


TERPENOIDS/TERPENES*+
Phytocannabinoids beyond the Cannabis plant – do they exist? (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/?tool=pubmed
Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. (click “leidenuniv” for download – 2010) https://scholar.google.com/scholar?cluster=480727757513022810&hl=en&as_sdt=0,5&as_vis=1
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS SATIVA L. (link to PDF– 2011) https://www.researchgate.net/publication/235348187_Variations_in_Terpene_Profiles_of_Different_Strains_of_Cannabis_sativa_L
Cannabidiol, a Major Phytocannabinoid, as a Potent Atypical Inhibitor for Cytochrome P450 2D6. (link to download – 2011) http://dmd.aspetjournals.org/content/early/2011/08/05/dmd.111.041384.long
Terpenoid biosynthesis in trichomes—current status and future opportunities. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7652.2012.00737.x/full
Cannabis Strains: Do Cannabis Strains Differ? (article – 2012) http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
THE EFFECTS OF JAMONATE ON PLASTIDAL TERPENOIDS ON CANNABIS SATIVA L. AT VEGETATIVE STAGE. (abst – 2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=305238
Does a positive finding of tetrahydrocannabinol in the blood result from ingestion of Indian frankincense (Boswellia serrata)? (abst – 2012) http://www.unboundmedicine.com/medline/citation/22834359/%5BDoes_a_positive_finding_of_tetrahydrocannabinol_in_the_blood_
result_from_ingestion_of_Indian_frankincense_%28Boswellia_serrata%29 The endocannabinoid system, cannabinoids, and pain. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosome cruzi. (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671683/
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948289/
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa. (abst – 2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
top


THC/TETRAHYDROCANNABINOL
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917429/?tool=pmcentrez
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. (full – 2010) https://onlinelibrary.wiley.com/doi/full/10.1111/j.1556-4029.2010.01441.x
Tissue Engineering of Cartilage; Can Cannabinoids Help? (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034107/
Antitumorigenic Effects of Cannabinoids beyond Apoptosis. (click “aspetjournals” for download – 2010) http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Therapeutical use of the cannabinoids in psychiatry. (full – 2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice. (full – 2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/
Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed
Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131805/
Nutritional Interventions for Cancer-induced Cachexia. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106221/
Disposition of Cannabichromene, Cannabidiol, and Δ9-Tetrahydrocannabinol and its Metabolites in Mouse Brain following Marijuana Inhalation Determined by High- Performance Liquid Chromatography-Tandem Mass Spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023979/
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2. (full – 2010) http://pharmrev.aspetjournals.org/content/62/4/588.full
Modulation of Adipocyte Biology by Δ9-Tetrahydrocannabinol. (full – 2010) http://onlinelibrary.wiley.com/doi/10.1038/oby.2010.100/full
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967639/
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
THC Prevents MDMA Neurotoxicity in Mice. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. (full – 2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). (full – 2010) http://ijnp.oxfordjournals.org/content/13/7/905.long
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. (full – 2010) http://www.jpsmjournal.com/article/S0885-3924(09)00787-8/fulltext
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms. (full – 2010) http://www.mdpi.com/1424-8247/3/7/2163/htm
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. (full – 2010) http://www.mdpi.com/1424-8247/3/8/2647/htm
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival. (full – 2010) http://mct.aacrjournals.org/content/9/1/180.full
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. (full – 2010) http://molpharm.aspetjournals.org/content/77/5/854.long
Simultaneous quantification of cannabinoids and metabolites in oral fluid by two- dimensional gas chromatography mass spectrometry. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849720/
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835116/
Mechanisms of Broad-Spectemetic Efficacy of Cannabinoids against Chemotherapy- Induced Acute and Delayed Vomiting. (full – 2010) http://www.mdpi.com/1424-8247/3/9/2930/htm
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. (full – 2010) http://onlinelibrary.wiley.com/doi/10.1002/eji.201040667/full
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923489/
Standardized Cannabis in Multiple Sclerosis: A Case Report. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Pharmacological characterization of GPR55, a putative cannabinoid receptor. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874616/
US Patent 7674922 B2 Process for production of delta-9-tetrahydrocannabinol. (full – 2010) http://www.google.com/patents/US7674922
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A) ― 2010-01-16. (full – 2010) https://patents.google.com/patent/TW201002315A/en?oq=Patent++TW201002315++(A)+%E2%80%95+2010-01-16
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. (link to full – 2010) http://bjp.rcpsych.org/content/197/4/285.long
Concentrations of delta9-tetrahydrocannabinol and 11-nor-9- carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. (link to PDF – 2010) http://jat.oxfordjournals.org/content/34/4/196.long
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis. (link to PDF – 2010) https://www.researchgate.net/publication/44592326_The_results_of_an_experimental_indoor_hydroponic_Cannabis_growing_study_using_the_’Screen_of_Green’_ScrOG_method-Yield_tetrahydrocannabinol_THC_and_DNA_analysis
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells. (link to PDF – 2010) https://www.researchgate.net/publication/44643739_Cannabinoids_Inhibit_Cellular_Respiration_of_Human_Oral_Cancer_Cells
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010. (link to download – 2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders. (link to download – 2010) http://www.eurekaselect.com/85221/article
The Role of Cannabinoid Receptors in the Descending Modulation of Pain. (link to PDF– 2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. (link to download – 2010) https://www.researchgate.net/publication/44683223_Meta-analysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008. (link to download – 2010) http://www.shd.org.rs/JSCS/Vol75/No7/02_4595_4015.pdf
Endocannabinoids and psychiatric disorders: the road ahead. (article – 2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500003&lng=en&nrm=iso&tlng=en
Delta-9-Tetrahydrocannabinol Disruption of Time Perception and of Self-Timed Actions. (letter – 2010) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0030-1255030
Tocolytic Effect of Δ9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide— Induced Preterm Delivery: Role of Nitric Oxide. (abst – 2010) http://journals.sagepub.com/doi/abs/10.1177/1933719109358456
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti- invasion activity at low concentration and apoptosis induction at high concentration. (abst – 2010) https://www.semanticscholar.org/paper/The-dual-effects-of-delta(9)-tetrahydrocannabinol-Leelawat-Leelawat/c5a9615a5f9d9843b5142e3f053a5e12cedd3bd1
Variation in Δ9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L. During Different Stages of Growth. (abst – 2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251775
Chronic cannabinoid administration lowers viral replication in lymph nodes of SIV infected Rhesus macaques. (abst – 2010) https://www.fasebj.org/doi/10.1096/fasebj.24.1_supplement.752.6
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. (abst – 2010) https://www.semanticscholar.org/paper/Tetrahydrocannabinol-(THC)-for-cramps-in-lateral-a-Weber-Goldman/18d5419100448cf6ca7a4db1989462dad1829a16
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform- selective and potent inhibitors of human CYP1 enzymes. (abst – 2010) http://www.sciencedirect.com/science/article/pii/S0006295210000663
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20520294
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9- tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
Postmortem redistribution of THC in the pig. (abst – 2010) https://www.semanticscholar.org/paper/Postmortem-redistribution-of-THC-in-the-pig-Brunet-Hauet/07fc53c727f460927b64685e48b7a210cdad3dc4
DOSE-DEPENDENT EFFECTS ON VENTILATION AT REST INDUCED BY HIGH DOSES OF CANNABINOIDS IN RATS. (abst – 2010) http://www.tandfonline.com/doi/abs/10.1179/acb.2010.115
Direct detection of Delta9-tetrahydrocannabinol in saliva using a novel homogeneous competitive immunoassay with fluorescence quenching. (abst – 2010) https://www.sciencedirect.com/science/article/pii/S0003267009014974?via%3Dihub
Beyond acid suppression: new pharmacologic approaches for treatment of GERD. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20425477
Pharmacological Management of Pain in Patients with Multiple Sclerosis (abst–2010) https://link.springer.com/article/10.2165%2F11537930-000000000-00000
https://www.semanticscholar.org/paper/Pharmacological-Management-of-Pain-in-Patients-with-Solaro-Uccelli/94539e221fce90c3bced04fd7e20b73420ed812c
Cannabis with high cannabidiol content is associated with fewer psychotic experiences. (full – 2011) https://www.sciencedirect.com/science/article/pii/S0920996411002246?via%3Dihub
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388539/
Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131933/
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096803/
Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285765/
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. (full – 2011) https://academic.oup.com/annonc/article/22/9/2086/211788/Delta-9-tetrahydrocannabinol-may-palliate-altered
Heterogeneity in the composition of marijuana seized in California. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118261/
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727221/
Cannabinoid Neuroimmune Modulation of SIV Disease. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208744/
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex. (full – 2011) http://www.sciencedirect.com/science/article/pii/S0006899311001533
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645879/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
Combined effects of THC and caffeine on working memory in rats. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. (full – 2011) http://www.clinchem.org/content/57/1/66.long
The dual neuroprotective-neurotoxic profile of cannabinoid drugs. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
A combined preclinical therapy of cannabinoids and temozolomide against glioma. (full – 2011) http://mct.aacrjournals.org/content/10/1/90.full
Enhanced solubility, stability, and transcorneal permeability of delta-8- tetrahydrocannabinol in the presence of cyclodextrins. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134676/
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140653/?tool=pubmed
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413845/
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9- tetrahydrocannabinol on spatial memory. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055664/
Regulation of nausea and vomiting by cannabinoids. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137184/
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK- dependent activation of autophagy. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC313
1949/ Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842229/
Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH- THC), and 11-nor-9-carboxy-THC (THCCOOH). (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413259/
Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained, Monitored Abstinence. (full – 2011) http://clinchem.aaccjnls.org/content/57/8/1127.long
Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol. (full – 2011) http://acb.sagepub.com/content/49/2/194.long
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101004/
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033515/?tool=pmcentrez
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner. (full – 2011) https://www.academia.edu/35995703/Delta9_-THC_and_WIN55_212-
2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype-_compound-_dose-_and_region-specific_manner
Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164340/
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model. (link to PDF – 2011) http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing. (We need 8 to 11 mg of zinc daily; over 40 mg/day can cause nausea and zinc poisoning. ) (link to PDF – 2011) http://jat.oxfordjournals.org/content/35/6/333.long
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat. (link to PDF – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sex+Differences+in+Cannabinoid+1+vs.+Cannabinoid+2+Receptor-Selective+Antagonism+of+Antinociception+Produced+by+%CE%949-Tetrahydrocannabinol+and+CP55%2C940+in+the+Rat&btnG
Cannabinoids in oral fluid following passive exposure to marijuana smoke. (link to PDF – 2011) https://www.researchgate.net/publication/51496380_Cannabinoids_in_oral_fluid_following_passive_exposure_to_marijuana_smoke
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety. (link to PDF – 2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation. (link to PDF – 2011) https://www.researchgate.net/publication/49851195_Spontaneous_regression_of_septum_pellucidumforniceal_pilocytic_astrocytomas_-_Possible_role_of_Cannabis_inhalation
Cannabinoids in postmortem toxicology. (link to PDF – 2011) http://jat.oxfordjournals.org/content/35/7/394.long
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS SATIVA L. (link to PDF– 2011) https://www.researchgate.net/publication/235348187_Variations_in_Terpene_Profiles_of_Different_Strains_of_Cannabis_sativa_L
Detection of δ(9)-tetrahydrocannabinol in exhaled breath collected from cannabis users. (link to PDF – 2011) http://jat.oxfordjournals.org/content/35/8/541.long
Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits. (link to PDF – 2011) https://www.researchgate.net/publication/49764243_Bioavailability_of_D_9_-tetrahydrocannabinol_following_intranasal_administration_of_a_mucoadhesive_gel_spray_delivery_system_in_conscious_rabbits
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. (link to PDF – 2011) https://www.researchgate.net/publication/50249108_A_randomized_double-blind_placebo-controlled_parallel-group_enriched-design_study_of_nabiximols_Sativex_R_as_add-on_therapy_in_subjects_with_refractory_spasticity_caused_by_multiple_sclerosis Cannabinoid mediated diuresis in mice. (download – 2011) Cannabinoid mediated diuresis in mice – Northeastern University Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA. (link to download in English, link to French – 2011) http://www.google.it/patents/WO2010012506A1?cl=en
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells. (link to download– 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01461.x/pdf
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. (link to download – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
The draft genome and transcriptome of Cannabis sativa. (link to download – 2011) http://genomebiology.com/content/pdf/gb-2011-12-10-r102.pdf
The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys. (link to download – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188916/pdf/
top
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids. (link to download – 2011) http://www.dovepress.com/articles.php?article_id=7675
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L.). (link to download – 2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa. (link to download – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease. (click “academia” for download – 2011) https://scholar.google.com/scholar?q=Neuroprotective+effects+of+phytocannabinoid-
based+medicines+in+experimental+models+of+Huntington%27s+disease.&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. (click “researchgate” for download – 2011) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabidiol+potentiates+%CE%94%E2%81%B9-
tetrahydrocannabinol+%28THC%29+behavioural+effects+and+alters+THC+pharmacokinetics+during+acute+and+chronic+treatment +in+adolescent+rats.&btnG= Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. (click “rocmexico” for download – 2011) https://scholar.google.com/scholar?q=Cannabidiol+inhibits+lung+cancer+cell+invasion+and+metastasis+via+intercellular+adhesion+
molecule-1.&hl=en&as_sdt=0&as_vis=1&oi=scholart Prolonged excretion half-life of 11-nor-9-carboxy-Δ⁹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment. st (1 page – 2011) https://www.sciencedirect.com/science/article/pii/S0033318210000289?via%3Dihub
Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice. (abst – 2011) https://www.semanticscholar.org/paper/Treatment-with-tetrahydrocannabinol-(THC)-prevents-Bregman-
Fride/10b6042203d7418c3b397c493debf6708537ecff Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21512341
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy. (abst – 2011) http://www.degruyter.com/abstract/j/jbcpp.2011.22.issue-1-
2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid Effects of synthetic cannabinoids on electroencephalogram power spectra in rats. (abst – 2011) https://www.sciencedirect.com/science/article/pii/S0379073811002209?via%3Dihub
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (abst – 2011) https://www.semanticscholar.org/paper/THC-and-CBD-oromucosal-spray-(Sativex%C2%AE)-in-the-of-Sastre-Garriga-
Vila/4aff95e12c30cb7420e8705c55e59f965b6ae29d
A preliminary investigation on the distribution of cannabinoids in man. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21570784/abstract/A_preliminary_investigation_on_the_distribution_of_cannabinoids_in_man_
Pharmacokinetics of a combination of Δ9-tetrahydrocannabinol and celecoxib in a porcine model of hemorrhagic shock. (abst – 2011) https://www.semanticscholar.org/paper/Pharmacokinetics-of-a-combination-of-and-celecoxib-Vaddady-Mehrotra/cfbfbaf73e03f9e26a03ea778b066a46292d519b
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0166432811001094
Biotechnology of Cannabis sativa L. (abst – 2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273535
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726418
Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology. (abst – 2011) https://www.fasebj.org/doi/10.1096/fasebj.25.1_supplement.807.1
Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21636228
A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid (THCA) synthase gene in herbal Cannabis samples. (abst – 2011) https://www.sciencedirect.com/science/article/pii/S0379073811005299?via%3Dihub
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21381415/abstract/%5BSimultaneous_determination_of_delta_9_tetrahydrocannabinol_cannabidiol_and_cannabinol_in_edible_oil_using_ultra_performance_liquid_chromatography_tandem_mass_spectrometry %5D_
Antinociception and sedation following intracerebroventricular administration of Δ⁹- tetrahydrocannabinol in female vs. male rats. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0166432810005383
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011) http://www.sciencedirect.com/science/article/pii/S030439401100437X?via%3Dihub
Cannabinoids Inhibit Migration of Microglial-like Cells to the HIV Protein Tat. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21735070
https://www.semanticscholar.org/paper/Cannabinoids-Inhibit-Migration-of-Microglial-like-Fraga-Raborn/11454061a2c680cbb0ae07c5edde08b3891c0b29
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21716095/abstract/THC_methadone_and_THC_naltrexone_interactions_on_discrimination_antinociception_and_locomotion_in_rats_
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies. (full – 2012) http://onlinelibrary.wiley.com/doi/
10.1111/j.1476-5381.2012.02042.x/full Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12014/full
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525861/
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up- regulation of Serum IgE Levels in Immunized Mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Cannabidiol in humans-the quest for therapeutic targets. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
So what do we call GPR18 now? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423231/
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01497.x/full
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Rimonabant eliminates responsiveness to workload changes in a time-constrained food- reinforced progressive ratio procedure in rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
top
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. (full – 2012) http://www.cell.com/cell/fulltext/S0092-8674(12)00142-0
Acute effects of THC on time perception in frequent and infrequent cannabis users. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581701/
Review article: The endocannabinoid system in normal and pathological brain ageing. (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Involvement of the endocannabinoid system in reward processing in the human brain. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705914/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. (full – 2012) http://jnnp.bmj.com/content/83/11/1125.long
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258357/
Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
Brain regional differences in CB1 receptor adaptation and regulation of transcription. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772765/
Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697741/
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC- like Morris water maze deficits in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382457/
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936256/
Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194211/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities . (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
The Therapeutic Potential of Cannabis and Cannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717347/
Cannabis—A Valuable Drug That Deserves Better Treatment. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498425/
AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291515/
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Cannabinoid-associated cell death mechanisms in tumor models (Review). (full – 2012) http://www.spandidos-publications.com/ijo/41/2/407
Cannabinoids: A new hope for breast cancer therapy? (full – 2012) http://www.academia.edu/23263803/Cannabinoids_A_new_hope_for_breast_cancer_therapy
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ9- Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis. (full – 2012) http://jat.oxfordjournals.org/content/36/6/405.full
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. (full – 2012) http://ijnp.oxfordjournals.org/content/15/9/1251.long
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319321/
Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine. (full – 2012) http://www.clinchem.org/content/58/9/1364.full
Cannabinoids and value-based decision making: implications for neurodegenerative disorders. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496267/
NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL – Patent US2012052119 (A1) ― 2012-03-01 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012052119A1&KC=A1&FT=D&ND=3&date=20120301&DB=EPODOC&locale=en_EP
US Patent 8106244 B2 Process for production of delta-9-tetrahydrocannabinol (full – 2012) http://www.google.com/patents/US8106244
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200580/
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission (full–2012) https://www.academia.edu/22887765/Effect_of_delta-9-tetrahydrocannabinol_on_behavioral_despair_and_on_pre-_and_postsynaptic_serotonergic_transmission
Predictive model accuracy in estimating last Δ(9)-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. (full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461265/
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (full – 2012) https://www.cambridge.org/core/journals/primary-health-care-research-and-development/article/questionnaire-survey-of-patients-and-
carers-of-patients-prescribed-sativex-as-an-unlicensed-medicine/BEE125598FE8E6E92EC01F33DC5F149D/core-reader
Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease. (full – 2012) https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2990.2011.01248.x
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. (link to PDF– 2012) https://www.researchgate.net/publication/232066502_Cannabidiol_inhibits_THC-elicited_paranoid_symptoms_and_hippocampal-dependent_memory_impairment The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia. (link to PDF – 2012) http://www.eurekaselect.com/102848/article
Treatment of Tourette syndrome with cannabinoids. (link to PDF – 2012) http://www.hindawi.com/journals/bn/2013/294264/abs/
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study. (link to PDF – 2012) https://www.researchgate.net/publication/230656362_Manipulating_brain_connectivity_with_d9-tetrahydrocannabinol_A_pharmacological_resting_state_FMRI_study Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis. (link to PDF – 2012) https://www.researchgate.net/publication/224976485_Single-dose_Pharmacokinetics_and_Tolerability_of_Oral_Delta-9-_Tetrahydrocannabinol_in_Patients_with_Amyotrophic_Lateral_Sclerosis
Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study. (link to PDF – 2012) https://www.researchgate.net/publication/51782734_Effects_of_D9-
Tetrahydrocannabinol_Administration_on_Human_Encoding_and_Recall_Memory_Function_A_Pharmacological_fMRI_Study
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (link to PDF – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Heat+Exposure+of+Cannabis+sativa+Extracts+Affects+the+Pharmacokinetic+and+Metabolic+Profile+in+Healthy+Male+Subjects.++++++++++++&btnG=
top
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. (link to PDF – 2012) https://www.researchgate.net/publication/227707560_Acute_Effects_of_a_Single_Oral_dose_of_d9-tetrahydrocannabinol_THC_and_Cannabidiol_CBD_Administration_in_Healthy_Volunteers
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)- tetrahydrocannabinol (THC): neuroprotection and ERK signaling. (link to download – 2012) https://www.theroc.us/researchlibrary/Long%C2%ADterm%20behavioral%20and%20biochemical%20effects%20of%20an%20ultra%C2%ADlow%20dose%20of%20D9%C2%ADtetrahydrocannabinol%20(THC)-%20neuroprotection%20and%20ERK%20signaling.pdf
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation. (link to download– 2012) http://www.eurekaselect.com/102849/article
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations. (click “uni-bonn” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoid+CB1+receptor+in+the+modulation+of+stress+coping+behavior+in+mice%3A+The+role+of+serotonin+and+different+forebrain+neuronal+subpopulations&btnG=
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells. (click “researchgate” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%E2%88%86%289%29-
Tetrahydrocannabinol+decreases+NOP+receptor+density+and+mRNA+levels+in+human+SH-SY5Y+cells.&btnG
Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. (click “unito” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Simultaneous+analysis+of+several+synthetic+cannabinoids%2C+THC%2C+CBD+and+CBN%2C+in+hair+by+ultra-high+performance+liquid+chromatography+tandem+mass+spectrometry.+Method+validation+and+application+to+real+samples.+++ +++++++&btnG Minireview: Endocannabinoids and Gonadal Hormones: Bidirectional Interactions in Physiology and Behavior. (click “oup” for download – 2012) https://scholar.google.com/scholar?q=Minireview:+Endocannabinoids+and+Gonadal+Hormones:+Bidirectional+Interactions+in+Physiology+and+Behavior.&hl=en&as_sdt=0&as_vis=1&oi=scholart
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (click “researchgate” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+double-blind%2C+randomized%2C+placebo-controlled%2C+parallel-group+study+of+THC%2FCBD+oromucosal+spray+in+combination+with+the+existing+treatment+regimen%2C+in+the+relief+of+central+neuropathic+pain+in+patients+with+multiple+sclerosis.&btnG
Sniffing out pharmacology: interactions of drugs with human olfaction. (click “academia” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sniffing+out+pharmacology%3A+interactions+of+drugs+with+human+olfaction.++&btnG
Cannabis Strains: Do Cannabis Strains Differ? (article – 20 12) http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. (abst in English – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
(abst in Spanish – 2012) https://www.neurologia.com/articulo/2012362
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) https://www.sciencedirect.com/science/article/pii/S0944711312001249?via%3Dihub
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures. (abst – 2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
Evidence That A Functional Gpr18-based Signaling System In The Anterior Murine Eye Modulates Intraocular Pressure. (abst – 2012) http://iovs.arvojournals.org/article.aspx?articleid=2358806&resultClick=1
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabidiol-for-the-treatment-of-cannabis-syndrome%3A-Crippa-Hallak/b932e4334e490493ed91b84b187b8ebe906c6e4f
Distribution of free and conjugated cannabinoids in human bile samples. (abst – 2012) https://www.semanticscholar.org/paper/Distribution-of-free-and-conjugated-cannabinoids-in-Fabritius-Staub/607db7f1f6ce6873db87ca3ba75b5b71fa0d56c7
Dried Blood Spots: Liquid chromatography-mass spectrometry analysis of Δ(9)- tetrahydrocannabinol and its main metabolites. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0021967312017608
https://www.semanticscholar.org/paper/Dried-blood-spots%3A-liquid-chromatography-mass-of-Mercolini-Mandrioli/78e28f77265a62134b1212448ecf368838138607
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis. (abst – 2012) https://www.semanticscholar.org/paper/Cost-Effectiveness-of-Oromucosal-Cannabis-Based-for-Lu-Pearce/7cdfdacafb20ea0ef8c65546ab2d1035fb06ab96
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. (abst – 2012) https://www.semanticscholar.org/paper/First-systematic-evaluation-of-the-potency-of-grown-Bruci-Papoutsis/3d18eacca6c5e342ef26ad73fd7fea27aa137fa7
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. (abst – 2012) https://www.semanticscholar.org/paper/Cannabis-derivatives-therapy-for-a-seronegative-a-Vicente-Valor-Garcia-Llopis/08926d1160224a16a1b8ae6cdcc4810ebe467b0b
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674350/
Modulating the endocannabinoid system in human health and disease: successes and failures. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684164/
Diuretic effects of cannabinoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. (full – 2013) http://www.springerplus.com/content/2/1/236
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/
Parsing the players: 2-AG synthesis and degradation in the CNS. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12411/full
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656362/
Towards a better Cannabis drug. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) https://www.sciencedirect.com/science/article/pii/S2173580814000674
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/7
1 Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Induction of the fatty acid 2-hydroxylase (FA2H) gene by ∆9-tetrahydrocannabinol in human breast cancer cells (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018719/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol. (full – 2013) https://www.sciencedirect.com/science/article/pii/S0924977X13001958
Influence of Ethanol on the Pharmacokinetic Properties of Δ9-Tetrahydrocannabinol in Oral Fluid. (full – 2013) http://jat.oxfordjournals.org/content/37/3/152.full
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
The endocannabinoid system, cannabinoids, and pain. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Amygdala activity contributes to the dissociative effect of cannabis on pain perception. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549497/
Cannabinoid facilitation of fear extinction memory recall in humans. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. (full – 2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685885/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120. (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476243/
Effect of Cannabinoid Receptor Activation on Spreading Depression. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Pharmacokinetic and Pharmacodynamic Profile of Supratherapeutic Oral Doses of Δ9 – THC in Cannabis Users. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691290/
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838683/
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9- THC: Mechanism underlying greater toxicity? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945037/
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health. (full – 2013) http://www.hindawi.com/journals/sci/2013/796715/
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. (full – 2013) http://ijnp.oxfordjournals.org/content/16/10/2273
Marijuana’s dose-dependent effects in daily marijuana smokers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547548/
Diuretic effects of cannabinoid agonists in mice. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872476/
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid- Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634783/
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants. (full – 2013) http://www.mdpi.com/1420-3049/18/10/12663/htm
Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053165/
Cannabis, a complex plant: different compounds and different effects on individuals. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758774/
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9- Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102264/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
Epigenetics, drugs of abuse, and the retroviral promoter. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878082/
Why should Cannabis be Considered Doping in Sports? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized, Controlled Crossover Clinical Trial For Pain. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013220/
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054795
Critical appraisal of the potential use of cannabinoids in cancer management. (full – 2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770515/
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (link to PDF – 2013) https://www.researchgate.net/publication/235905283_Natural_Cannabinoids_Improve_Dopamine_Neurotransmission_and_Tau_and_
Amyloid_Pathology_in_a_Mouse_Model_of_Tauopathy Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. (link to PDF – 2013) https://www.researchgate.net/publication/253334787_Cannabinoids_Decrease_the_Th17_Inflammatory_Autoimmune_Phenotype
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. (link to PDF – 2013) https://www.researchgate.net/publication/231523388_Cannabis_affects_people_differently_Inter-
subject_variation_in_the_psychotogenic_effects_of_D9- tetrahydrocannabinol_A_functional_magnetic_resonance_imaging_study_with_healthy_volunteers A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray. (link to PDF – 2013) https://www.researchgate.net/publication/264266057_A_Multiple-Dose_Randomized_Double-Blind_Placebo-Controlled_Parallel-
Group_QTQTc_Study_to_Evaluate_the_Electrophysiologic_Effects_of_THCCBD_Spray Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines (link to PDF–2013) https://www.researchgate.net/publication/239732960_Preparation_and_characterization_of_D_9_-tetrahydrocannabinol-loaded_biodegradable_polymeric_microparticles_and_their_antitumoral_efficacy_on_cancer_cell_lines
Development and validation of an LC-MS/MS method for quantification of Δ9- tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair (link to PDF–2013) https://www.researchgate.net/publication/235398312_Development_and_validation_of_an_LC-MSMS_method_for_quantification_of_Delta_9-tetrahydrocannabinolic_acid_A_THCA-A_THC_CBN_and_CBD_in_hair
Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey. (click “academia” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Comparison+between+self-report+of+cannabis+use+and+toxicological+detection+of+THC%2FTHCCOOH+in+blood+and+THC+in+oral+fluid+in+drivers+in+ a+roadside+survey.&btnG
Therapeutic potential of cannabinoid medicines (click “psu” for download – 2013) https://scholar.google.com/scholar?q=%22+Therapeutic+potential+of+cannabinoid+medicines%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency. (link to download – 2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. (click “aspetjournals” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Combined+antiproliferative+effects+of+the+aminoalkylindole+WIN55%2C212-2+and+radiation+in+breast+cancer+cells.+++++++++++++&btnG The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action. (click “ucm” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+pseudokinase+tribbles+homologue-3+plays+a+crucial+role+in+cannabinoid+anticancer+action.++++++&btnG
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function. (letter – 2013) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0032-1316342
Medicinal Cannabis and Painful Sensory Neuropathy. (editorial – 2013) https://journalofethics.ama-assn.org/article/medicinal-cannabis-and-painful-sensory-neuropathy/2013-05
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L. (abst – 2013) https://link.springer.com/article/10.1007/BF00276675?no-access=true
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. (abst – 2013) http://www.tandfonline.com/doi/full/10.3109/03602532.2013.849268
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol? (abst–2013) http://journals.sagepub.com/doi/full/10.1177/0269881112446534
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9- THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva). (abst – 2013) http://www.sciencedirect.com/science/article/pii/S001429991300767X
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23363354
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Cannabis and Δ(9)-tetrahydrocannabinol (THC) for weight loss? (abst – 2013) https://www.semanticscholar.org/paper/Cannabis-and-%CE%949-tetrahydrocannabinol-(THC)-for-loss-Foll-Trigo/825e51737f6240d51cbddc11b7b3c498bc659f37
top
Non-psychotropic analgesic drugs from the endocannabinoid system: “magic bullet” or “multiple-target” strategies? (abst – 2013) https://www.semanticscholar.org/paper/Non-psychotropic-analgesic-drugs-from-the-system%3A-Starowicz-Marzo/e412302f98b0c79a97731c05056ce80ca769f549
An ultra-low dose of tetrahydrocannabinol provides cardioprotection. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0006295213001950
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
Induction of the fatty acid 2-hydroxylase (FA2H) gene by ∆9-tetrahydrocannabinol in human breast cancer cells. (link to download – 2013) https://www.jstage.jst.go.jp/article/jts/38/2/38_305/_pdf
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁. (click “researchgate” for download – 2013) https://scholar.google.com/scholar?q=Toxicological+profiles+of+selected+synthetic+cannabinoids+showing+high+binding+affinitiesto+the+cannabinoid+receptor+subtype+CB1&hl=en&as_sdt=0&as_vis=1&oi=scholart
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9- tetrahydrocannabinol in the rat. (click “theroc” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sex+differences+in+anti-allodynic%2C+anti-hyperalgesic+and+anti-edema+effects+of+%CE%94%289%29-tetrahydrocannabinol+in+the+rat.&btnG
Do cannabinoids exhibit a tyramine-like effect? (click “unibonn” for download – 2013) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Do+cannabinoids+exhibit+a+tyramine-like+effect%3F&btnG
Effects of anandamide and other CB1 ligands on cognitive function. (abst – 2013) https://www.fasebj.org/doi/10.1096/fasebj.27.1_supplement.1097.10
Conditioned taste aversion elicited by synthetic cannabinoid JWH-018 in mice is attenuated by pretreatment with phytocannabinoid {Delta}9-THC. (abst – 2013) https://www.fasebj.org/doi/abs/10.1096/fasebj.26.1_supplement.660.4
Interrogating Therapeutic Manipulation of the Endocannabinoid System in Human Colon. (abst – 2013) http://www.fasebj.org/content/26/1_Supplement/1123.1
Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23896215
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0091305712002985
Exercise increases plasma THC concentrations in regular cannabis users. (abst – 2013) https://www.sciencedirect.com/science/article/pii/S0376871613002962?via%3Dihub
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro. (abst – 2013) https://www.semanticscholar.org/paper/Cannabinoid-Effects-on-%CE%B2-Amyloid-Fibril-and-and-In-Janefjord-Maag/641ebdd551d8ae69283c3ace38d72755e8d957eb
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease. (abst – 2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats. (abst – 2013) https://www.semanticscholar.org/paper/Biochemical-and-immunohistochemical-changes-in-type-Coskun-Bolkent/503430aefd20479be3379f0325239549c46066cc
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation. (abst – 2013) https://www.semanticscholar.org/paper/Decreased-enteric-fatty-acid-amide-hydrolase-is-in-Zhang-Wang/011ed1a585a8504a512f5ee02cde952c07870d66
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells . (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE. (abst – 2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva). (abst – 2013) https://www.semanticscholar.org/paper/Additive-antiemetic-efficacy-of-low-doses-of-the-of-Darmani-/1d8a0e3d960b1097fa727e1ee4704870316f93d6
Molecularly imprinted solid phase extraction for simultaneous determination of Δ(9)- tetrahydrocannabinol and its main metabolites by gas chromatography-mass spectrometry in urine samples. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23890655
Cloud point extraction of Δ(9)-tetrahydrocannabinol from cannabis resin (abst–2013) https://www.semanticscholar.org/paper/Cloud-point-extraction-of-%CE%949-tetrahydrocannabinol-Ameur-Haddou/a819eabe19071859943ea4730b6b77f014bca2ea
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
top
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies. (full – 2014) http://www.karger.com/Article/FullText/357742
Getting high on the endocannabinoid system. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9- Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia. (full – 2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954478/
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http://www.neurology.org/content/82/17/1556.long
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131522/
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250392/
Evaluation of sex differences in cannabinoid dependence. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971653/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9- tetrahydrocannabinolic acid A concentrations. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
top
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (full – 2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/’Spice’ constituent JWH-018 in mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157458/
Modulation of Gut-Specific Mechanisms by Chronic Δ9-THC Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046212/
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
The case for medical marijuana in epilepsy. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243853/
Blood levels do not predict behavioral or physiological effects of Δ⁹- tetrahydrocannabinol in rhesus monkeys with different patterns of exposure. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251811/
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945413/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9- tetrahydrocannabinol (THC) by vaporization . (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12746/full
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081916/
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques. (full – 2014) http://jvi.asm.org/content/89/2/1168.long
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161674/
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209152/
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. (full – 2014) http://mct.aacrjournals.org/content/13/12/2955.long
Differences in Δ9-Tetrahydrocannabinol Metabolism and In Vivo Pharmacology Following Acute and Repeated Dosing in Adolescent Rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106361/
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons. (full – 2014) http://www.jbc.org/content/289/36/24845.long
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243870/
Cannabinoids in experimental stroke: a systematic review and meta-analysis. (full – 2014) http://jcb.sagepub.com/content/35/3/348.long
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159426/
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960373/
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209205/
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362971/
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9- tetrahydrocannabinol in Sprague-Dawley rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376456/
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ9-tetrahydrocannabinol administration (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312266/
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340656/
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110679/
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered- Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (full–2014) https://www.academia.edu/22926463/The_Pharmacokinetics_Efficacy_Safety_and_Ease_of_Use_of_a_Novel_Portable_Metered-Dose_Cannabis_Inhaler_in_Patients_With_Chronic_Neuropathic_Pain_A_Phase_1a_Study
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice. (full – 2014) http://www.jneurosci.org/content/34/15/5152.long
Cannabinoids as therapeutic agents in cancer: current status and future implications. (full – 2014) http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233&path%5B%5D=3664
Blood levels do not predict behavioral or physiological effects of Δ⁹- tetrahydrocannabinol in rhesus monkeys with different patterns of exposure (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251811/
Detection and Prevalence of Drug Use in Arrested Drivers Using the Dräger Drug Test 5000 and Affiniton DrugWipe Oral Fluid Drug Screening Devices. (full – 2014) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bku050
Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019698/
High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363114/
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201274/
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis (full–2014) http://www.neurology.org/content/82/12/1083.full
Urine Toxicology Screen in Multiple Sleep Latency Test: The Correlation of Positive Tetrahydrocannabinol, Drug Negative Patients, and Narcolepsy. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298782/
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042670/
Anti-tumoural effects of cannabinoid combinations – US 8632825 B2. (full – 2014) https://www.google.com/patents/US8632825?dq=patent+cannabinoid&hl=en&sa=X&ei=M1DyU6KwDYHcOuy6gLgF&ved=0CDM
Q6AEwAw Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems. (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948289/
Cannabis in the Management and Treatment of Seizures and Epilepsy: A Scientific Review. (full – 2014) https://herbal-ahp.org/scientific-review-cannabis-epilepsy-and-seizures/
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents. (full – 2014) https://www.academia.edu/8021310/A_vapourized_%CE%949-tetrahydrocannabinol_%CE%949-THC_delivery_system_part_II_Comparison_of_behavioural_effects_of_pulmonary_versus_parenteral_cannabinoid_exposure_in_rodents
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. (full – 2014) https://www.researchgate.net/publication/269176637_Involvement_of_central_and_peripheral_cannabinoid_receptors_on_antinociceptive_effect_of_tetrahydrocannabinol_in_muscle_pain
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice. (link to PDF – 2014) https://www.researchgate.net/publication/264833175_Cannabis-
Based_Medicine_Reduces_Multiple_Pathological_Processes_in_AbPPPS1_Mice
The Potential Therapeutic Effects of THC on Alzheimer’s Disease. (link to PDF – 2014) https://www.researchgate.net/publication/263934329_The_Potential_Therapeutic_Effects_of_THC_on_Alzheimer%27s_Disease
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (link to PDF–2014) https://www.researchgate.net/publication/267272822_Evaluation_of_the_tolerability_and_efficacy_of_Sativex_in_multiple_sclerosis
Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences. (link to PDF – 2014) https://www.researchgate.net/publication/261328095_Fasting_and_exercise_increase_plasma_cannabinoid_levels_in_THC_pre-treated_rats_an_examination_of_behavioural_consequences
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. (link to PDF– 2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCA-
A_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (link to PDF–2014) https://www.researchgate.net/publication/262842996_Just_say_’know’_How_do_cannabinoid_concentrations_influence_users’_estimates_of_cannabis_potency_and_the_amount_they_roll_in_joints
Early phytocannabinoid chemistry to endocannabinoids and beyond (link to PDF–2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (download–2014) https://www.cadth.ca/sites/default/files/pdf/htis/may-2016/RB0983%20Sativex%20for%20MS%20Final.pdf
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical- Grade Cannabis (link to download–2014) https://bedrocan.com/wp-content/uploads/2014-therapeutic-satisfaction-and-subjective-effects-of-different-strains-of-pharmaceutical-grade-cannabis_-brunt.pdf
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs. (link to download – 2014) https://www.academia.edu/23883480/Inhibition_of_endocannabinoid_neuronal_uptake_and_hydrolysis_as_strategies_for_developing_anxiolytic_drugs
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents. (link to download – 2014) https://www.academia.edu/8021310/A_vapourized_%CE%949-tetrahydrocannabinol_%CE%949-THC_delivery_system_part_II_Comparison_of_behavioural_effects_of_pulmonary_versus_parenteral_cannabinoid_exposure_in_rodents
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (link to download – 2014) http://www.karger.com/Article/Pdf/367615
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. (link to download – 2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representation=PDF
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists. (click “aspetjournals” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Impact+of+efficacy+at+the+mu+opioid+receptor+on+antinociceptive+effects+of+combinations+of+mu+opioid+receptor+agonists+and+cannabinoid+receptor+agonists&btnG
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. (click “academia” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cross-
sectional+and+prospective+relation+of+cannabis+potency%2C+dosing+and+smoking+behaviour+with+cannabis+dependence%3A+ an+ecological+study.&btnG=
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (click “Marquette” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cyclic+ovarian+hormone+modulation+of+supraspinal+%CE%949- tetrahydrocannabinol-induced+antinociception+and+cannabinoid+receptor+binding+in+the+female+rat&btnG
Effect of marijuana use on outcomes in traumatic brain injury. (click “semanticscholar” for download – 2014) https://scholar.google.com/scholar?q=Effect+of+marijuana+use+on+outcomes+in+traumatic+brain+injury.&hl=en&as_sdt=0&as_vis=1&oi=scholart Current knowledge on cannabinoids in oral fluid. (click “wiley” for download – 2014) https://scholar.google.com/scholar?q=Current+knowledge+on+cannabinoids+in+oral+fluid&hl=en&as_sdt=0&as_vis=1&oi=scholart http://www.ingentaconnect.com/search/article?option1=tka&value1=Current+knowledge+on+cannabinoids+in+oral+fluid&pageSize
=10&index=1
Acute subjective effects after smoking joints containing up to 69 mg Δ9- tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial. (click “bedrocan” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Acute+subjective+effects+after+smoking+joints+containing+up+to+69+mg+%CE%949-tetrahydrocannabinol+in+recreational+users%3A+a+randomized%2C+crossover+clinical+trial.&btnG
Cannabinoid-induced changes in respiration of brain mitochondria. (click “cuni” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoid-induced+changes+in+respiration+of+brain+mitochondria&btnG
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (click “researchgate” for download – 2014) https://scholar.google.com/scholar?q=Developmentally+vitamin+D-
deficient+rats+show+enhanced+prepulse+inhibition+after+acute+%CE%949- tetrahydrocannabinol.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial. (click “runl” for download – 2014) https://scholar.google.com/scholar?q=Safety+and+pharmacokinetics+of+oral+delta-9-
tetrahydrocannabinol+in+healthy+older+subjects:+A+randomized+controlled+trial&hl=en&as_sdt=0&as_vis=1&oi=scholart
Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. (click “researchgate” for download – 2014) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Comparative+effects+of+pulmonary+and+parenteral+%CE%94%E2%81%B9-tetrahydrocannabinol+exposure+on+extinction+of+opiate-induced+conditioned+aversion+in+rats.&btnG
Report on Medical Cannabis Research History- What the Science Says. (article – 2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Cannabinoids for epilepsy: is marijuana an effective treatment for epilepsy? st (link to 1 page – 2014) https://www.thieme-connect.com/products/ejournals/abstract/10.3233/PEP-14077
Therapeutic Potential of Cannabinoids—Perspectives for the Future. (abst in English & Japanese – 2014) http://www.tandfonline.com/doi/abs/10.1080/15440478.2013.878604
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis- related spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Profiling the subjective effects of Δ9 -tetrahydrocannabinol using visual analogue scales. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24496889
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
Acute administration of THC impairs spatial but not associative memory function in zebrafish. (abst – 2014) https://www.semanticscholar.org/paper/Acute-administration-of-THC-impairs-spatial-but-not-Ruhl-Prinz/8215c3246d0e2599d5040d9ca45a6443f0394b1b
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814000978?via%3Dihub
https://www.semanticscholar.org/paper/The-detection-of-THC%2C-CBD-and-CBN-in-the-oral-fluid-Molnar-
Fu/d49d12e576d1bc3ce430746bc011e9c3d12ba4ab Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006295214003608
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects. (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology. (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage. (abst – 2014) https://www.semanticscholar.org/paper/Ultralow-doses-of-cannabinoid-drugs-protect-the-Fishbein-Kaminietsky-Gafni/7543d1bbca2aa3d39ca4d5a241be95912881acb8
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington’s disease may depend on their functional selectivity. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.846.6
Pharmacokinetics and relative bioavailability of THC and THC-solid dispersion orally to mice at single dose. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24956859
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats. (abst – 2014) https://www.fasebj.org/doi/10.1096/fasebj.28.1_supplement.838.6
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE- ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006295214004201
https://www.semanticscholar.org/paper/Cannabinoids-increase-lung-cancer-cell-lysis-by-via-Haustein-Ramer/ae2a0a45c3a3e896a9986642c922fe6713526d08
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study. (abst – 2014) https://www.semanticscholar.org/paper/Cannabinoids-reward-sensitivity-in-a-animal-model-A-Gallo-Bouchard/4c8b7598cdaf5f28fcadbf733bff9df367b21479
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814003119?via%3Dihub
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified- PLGA nanoplatforms. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0927776514004615
Relationship between cannabinoids content and composition of fatty acids in hempseed oils. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0308814614012540
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response. (abst – 2014) https://www.epilepsybehavior.com/article/S1525-5050(14)00413-2/fulltext
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
Cannabinoids and schizophrenia: therapeutic prospects. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
The influence of personality on the sensitivity to subjective effects of Δ9- tetrahydrocannabinol. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0165178114008312
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S1355030614001075?via%3Dihub
Interaction Between the Endocannabinoid and Serotonergic System in the Exhibition of Head Twitch Response in Four Mouse Strains. (abst – 2014) https://link.springer.com/article/10.1007%2Fs12640-014-9510-z
https://www.semanticscholar.org/paper/Interaction-Between-the-Endocannabinoid-and-System-Ceci-Onori/bc1f77fa860bf914b2b9beb3f2a2d1aae99762a8
Potential applications of marijuana and cannabinoids in medicine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Stereodivergent Total Synthesis of Δ9-Tetrahydrocannabinols (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/ange.201408380/abstract
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism. (abst – 2014) https://www.semanticscholar.org/paper/Effects-of-%CE%949-tetrahydrocannabinol-in-individuals-a-Ranganathan-Sewell/9762ad966870e93d54de7e52c40e5dfcdb3c0914
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS. (abst – 2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Evaluation of Δ9 -tetrahydrocannabinol detection using DrugWipe5S® screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24753449
Detection Time for THC in Oral Fluid after Frequent Cannabis Smoking. (abst – 2014) https://www.semanticscholar.org/paper/Detection-time-for-THC-in-oral-fluid-after-frequent-And%C3%A5s-Krabseth/a9092273042f45f2ecd0133e141bfa881a335191
Preliminary, open-label, pilot study of add-on oral δ(9)-tetrahydrocannabinol in chronic post-traumatic stress disorder. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24935052
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
The influence of personality on the sensitivity to subjective effects of Δ9- tetrahydrocannabinol. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0165178114008312
Acute administration of THC impairs spatial but not associative memory function in zebrafish (abst–2014) https://www.semanticscholar.org/paper/Acute-administration-of-THC-impairs-spatial-but-not-Ruhl-Prinz/8215c3246d0e2599d5040d9ca45a6443f0394b1b
top


THC ACID/THCA
Hair analysis for Delta9-tetrahydrocannabinolic acid A–new insights into the mechanism of drug incorporation of cannabinoids into hair. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20129747
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
The draft genome and transcriptome of Cannabis sativa. (link to download – 2011) http://genomebiology.com/content/pdf/gb-2011-12-10-r102.pdf
Cannabis as a Unique functional food. (link to download – 2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
Immunochemical approach using monoclonal antibody against Δ(9)- tetrahydrocannabinolic acid (THCA) to discern cannabis plants and to investigate new drug candidates. (link to download – 2011) http://www.eurekaselect.com/94339/article
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa. (link to download – 2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid (THCA) synthase gene in herbal Cannabis samples. (abst – 2011) https://www.sciencedirect.com/science/article/pii/S0379073811005299?via%3Dihub
Terpenoid biosynthesis in trichomes—current status and future opportunities (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7652.2012.00737.x/full
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects. (link to PDF – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Heat+Exposure+of+Cannabis+sativa+Extracts+Affects+the+Pharmacokinetic+and+Metabolic+Profile+in+Healthy+Male+Subjects.++++++++++++&btnG=
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. (click “tu-dortmund-de” for download – 2012) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C48&q=Analysis+of+cannabinoids+in+laser-microdissected+trichomes+of+medicinal+Cannabis+sativa+using+LCMS+and+cryogenic+NMR&btnG=
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) https://www.sciencedirect.com/science/article/pii/S0944711312001249?via%3Dihub
Structure and Function of Δ1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0022283612005220
Distribution of free and conjugated cannabinoids in human bile samples (abst–2012) https://www.semanticscholar.org/paper/Distribution-of-free-and-conjugated-cannabinoids-in-Fabritius-Staub/607db7f1f6ce6873db87ca3ba75b5b71fa0d56c7 Extraction of high quality DNA from seized moroccan cannabis resin (hashish). (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792001/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Development and validation of an LC-MS/MS method for quantification of Δ9- tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair. (link to PDF – 2013) https://www.researchgate.net/publication/235398312_Development_and_validation_of_an_LC-MSMS_method_for_quantification_of_Delta_9-tetrahydrocannabinolic_acid_A_THCA-A_THC_CBN_and_CBD_in_hair
In planta imaging of Δ9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy. (download – 2013) http://os.tnw.utwente.nl/publications/pdf/237.pdf
Analysis of THCA synthase gene expression in cannabis: A preliminary study by real- time quantitative PCR. (click “the-eye” for download – 2013) https://scholar.google.com/scholar?q=Analysis+of+THCA+synthase+gene+expression+in+cannabis:+A+preliminary+study+by+real-time+quantitative+PCR&hl=en&as_sdt=0&as_vis=1&oi=scholart
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1352335
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916817/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9- tetrahydrocannabinolic acid A concentrations. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases. (full – 2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. (link to PDF– 2014) http://www.researchgate.net/publication/236185970_Hair_analysis_for_THCA-
A_THC_and_CBN_after_passive_in_vivo_exposure_to_marijuana_smoke A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
A PCR marker Linked to a THCA synthase Polymorphism is a Reliable Tool to Discriminate Potentially THC-Rich Plants of Cannabis sativa L. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24579739
Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S0379073814003119?via%3Dihub
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25005819
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures. (abst – 2014) https://www.sciencedirect.com/science/article/pii/S089203621400172X?via%3Dihub
top


TETRAHYDROCANNABIORCOL
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol. (full – 2011) http://www.nature.com/ncomms/journal/v2/n11/full/ncomms1559.html


THCV/TETRAHYDROCANNABIVARIN/GWP-42004*+
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931567/?tool=pubmed
Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. (full – 2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2010.02523.x/full
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers. (download – 2010) home.olemiss.edu/~suman/Geneticstability.pdf
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes. (research summary – 2010) https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/gwmd1092-gw42003gw42004-
together-plus-alone-in-type-ii-diabetes/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. (full – 2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/
CB(1) -independent mechanisms of Δ(9) -THCV, AM251 and SR141716 (rimonabant). (full – 2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.2011.01284.x/full
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS . (full – 2011) http://www.faqs.org/patents/app/20110082195
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in animal models of Parkinson’s disease. (link to download – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive- compulsive behaviour. (abst – 2011) https://link.springer.com/article/10.1007%2Fs00213-011-2415-0
https://www.semanticscholar.org/paper/Plasma-and-brain-pharmacokinetic-profile-of-(CBD)%2C-Deiana-Watanabe/dfc11f2878a906a6a68316691d9182d02111851a
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726418
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions. (abst – 2011) https://www.semanticscholar.org/paper/In-vitro-germplasm-conservation-of-high-yielding-of-Lata-Chandra/575be820fdf70580158ef8dce87eb56f0e451d8f
Δ(8) -Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
The Endocannabinoid System: Cannabinoids in Diabetes and Diabetic Complications. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
Δ(8) -Tetrahydrocannabivarin protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress and inflammatory response involving CB(2) receptors. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01410.x/full
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy (full–2012) https://patents.google.com/patent/US20120004251A1/en
Phytocannabinoids as novel therapeutic agents in CNS disorders. (link to PDF – 2012) https://www.researchgate.net/publication/51648721_Phytocannabinoids_as_novel_therapeutic_agents_in_CNS_disorders
Tailoring Your High: Compounds in Cannabis, Properties and Boiling Points. (chart – 2012) http://www.weedist.com/2012/07/tailoring-high-compounds-in-cannabis-properties-boiling-points/
THCVA-A – a new additional marker for illegal cannabis consumption. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0379073811001150
The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671751/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 – tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792004/
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Cannabis, a complex plant: different compounds and different effects on individuals. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control). (full – 2013) http://www.freepatentsonline.com/y2013/0245110.html
Neuritogenic Effects of Cannabinoids with Nerve Growth Factor (NGF) on PC12 Cells. (abst – 2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336533
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0091305712002985
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers. (full – 2014) http://ijnp.oxfordjournals.org/content/18/6/pyu094.long
top


THCVA/TETRAHYDROCANNABIVARIC ACID
THCVA-A – a new additional marker for illegal cannabis consumption. (abst – 2012) http://www.sciencedirect.com/science/article/pii/S0379073811001150
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro- apoptotic effects and underlying mechanisms. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full


TETRAHYDROHONOKIOL
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells (full–2014) https://www.mdpi.com/1420-3049/19/1/1223/htm


TRANS-CARYOPHYLLENE
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury. (full – 2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway. (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0006291X13009157
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia. (abst – 2014) https://www.semanticscholar.org/paper/Trans-Caryophyllene-Suppresses-Hypoxia-Induced-by-Guo-Mou/7121e6bd116d69f8c72269d5dcd276305fb58f2e
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006291X14001399
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0944711313003097


TRITERPENES (See also AMYRINS)
Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
Discovery of Triterpenoids as Reversible Inhibitors of α/β-hydrolase Domain Containing 12 (ABHD12). (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045134/
18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity. (click “wiley” for download – 2014) https://scholar.google.com/scholar?q=18%CE%B2-glycyrrhetinic+acid+attenuates+anandamide-induced+adiposity+and+high-fat+diet+induced+obesity.&hl=en&as_sdt=0&as_vis=1&oi=scholart
top


Updated 16 October, 2019